Sommaire

• • ·Poster Exhibit Task Force

    Page :A1

    Plan Plan
• • ·Poster Abstracts

    Page :A2

    
• • ·Table of Contents

    Page :A3

    
• • ·Editorial Board

    Page :A5

    

• PD01—Procedural and Aesthetic Dermatology

  • ·Chronic lymphocytic leukemia diagnosed during Mohs micrographic surgery: Implications for management

    Page :AB1

    
  • ·Electrosurgical coagulation of a deep infantile hemangioma using a penetrating insulated electrode: Disease modification with minimal superficial scarring

    Page :AB1

    
  • ·Knowledge about acne vulgaris among Saudi female youths

    Page :AB1

    
  • ·Open-label pharmacokinetic study to evaluate lipid levels in the blood following injections of ATX-101 (synthetically derived sodium deoxycholate)

    Page :AB1

    
  • ·Our experience regarding muscle weakness in the treatment of palmar hyperhidrosis with botulinum toxin type A

    Page :AB2

    
  • ·The versatility of the nasolabial transposition flap in midfacial reconstruction: Our experience

    Page :AB2

    

• PD02—Psoriasis

  • ·Access to health care in patients with psoriasis: Data from National Psoriasis Foundation survey panels

    Page :AB2

    
  • ·Cost-effectiveness of biologic therapies for plaque psoriasis: A systematic review

    Page :AB2

    
  • ·Expression of the serotonin transporter protein in psoriasis is correlated with the severity of the disease and chronic stress

    Page :AB3

    
  • ·Hepatitis C may predispose to psoriasis by upregulating cathelicidin, Toll-like receptor-9, and interferon-gamma

    Page :AB3

    
  • ·Lipopolysaccharide-binding protein, adipocyte fatty acid-binding protein, and retinol-binding protein-4: Potential indicators of metabolic syndrome in patients with psoriasis

    Page :AB3

    
  • ·Prevalence of entheses abnormalities in patients with nail and cutaneous psoriasis

    Page :AB3

    
  • ·Relatively high Foxp3/CD4 ratios in the symptomless skin of psoriatic patients suggesting active immune controlling mechanisms at a distance from the psoriatic plaque

    Page :AB4

    
  • ·The effect of weight loss in obese patients with chronic stable plaque-type psoriasis

    Page :AB4

    

• PD03—Pediatric Dermatology

  • ·Adverse cutaneous reactions to psychotropic medications in the pediatric population

    Page :AB4

    
  • ·Decreasing trends in melanoma incidence in children and adolescents from 2000 to 2009: A SEER analysis

    Page :AB4

    
  • ·Impact of acne treatment on inflammatory bowel disease

    Page :AB5

    
  • ·N-acetylcysteine in urea and lamellar ichthyosis

    Page :AB5

    
  • ·Pregnancy outcomes after maternal exposure to topical corticosteroids: A population-based cohort study

    Page :AB5

    
  • ·Propranolol therapy for infantile haemangiomas: A case series of 33 infants

    Page :AB5

    
  • ·Standardizing laboratory monitoring of patients undergoing isotretinoin treatment using a cost-effective and best evidence approach

    Page :AB6

    

• PD04—Skin Cancer

  • ·9p21 loss detected by FISH is associated with BRAF mutation in advanced melanoma

    Page :AB6

    
  • ·Characterizing peritumoral clefts in basal cell carcinoma with histologic staining and reflectance confocal microscopy

    Page :AB6

    
  • ·Correlation of hOGG1 protein expression and 8-OhDG adduct levels in actinic keratosis and cutaneous squamous cell carcinoma

    Page :AB6

    
  • ·Decreased folic acid serum level as risk factor for skin basal cell carcinoma development

    Page :AB7

    
  • ·Primary cutaneous CD30-positive T-cell lymphoproliferative disorders with biallelic rearrangements of the DUSP22-IRF4 locus on 6p25.3: Report of 3 cases

    Page :AB7

    
  • ·Quantification of ultraviolet radiation from salon fingernail lamps

    Page :AB7

    
  • ·Repigmentation of melanocytic tumor scars: Dermatoscopic features

    Page :AB7

    
  • ·The expression of B-defensins, cathelicidin (LL-37) in skin tumors

    Page :AB8

    

• PD05—Clinical Dermatology

  • ·Adult-onset Still disease in a geriatric patient: Updates and pearls in diagnosis

    Page :AB8

    
  • ·Alitretinoin in the treatment of hidradenitis suppurativa: An insight

    Page :AB8

    
  • ·Alternative treatments of vitamin D deficiency

    Page :AB8

    
  • ·Cutaneous hypersensitivity to gluten

    Page :AB9

    
  • ·End organ damage in levamisole adulterated cocaine: More than just purpura and agranulocytosis

    Page :AB9

    
  • ·Important evidence for anatomic predetermination: The auto-mirroring phenomenon in skin

    Page :AB9

    
  • ·Itch in familial lichen amyloidosis: Novel treatment with amitriptyline in 2 cases

    Page :AB9

    
  • ·The biologic effects of adipose-derived stem cells on wound healing in a mouse model

    Page :AB10

    

• PD06—Infectious Disease

  • ·A systematic review of systemic antifungals to treat onychomycosis in children

    Page :AB10

    
  • ·Antibiotic resistant Staphylococcus aureus and group B streptococcus in pediatric patients with atopic dermatitis

    Page :AB10

    
  • ·Molecular determination of nondermatophyte mold infections and mixed infections containing dermatophytes in putative onychomychosis patients referred to a dermatologist

    Page :AB10

    
  • ·Nitrosoglutathione-generating nitric oxide nanoparticles as an improved strategy for combating Pseudomonas aeruginosa–infected wounds

    Page :AB11

    
  • ·Nontuberculous mycobacterial cutaneous inoculation after professional tattooing: A case series and epidemiologic study

    Page :AB11

    
  • ·Onychomycosis: A complex disease?

    Page :AB11

    
  • ·Onychomycosis: What do we consider/how do we define cure and what are the barriers to achieving it?

    Page :AB11

    

• Acne

  • ·A double-blind, placebo-controlled evaluation of a 2% salicylic acid cleanser for improvement of acne vulgaris

    Page :AB12

    
  • ·A metaanalysis to investigate the relationship between Fitzpatrick skin types and tolerability of adapalene–benzoyl peroxide topical gel in patients with mild or moderate acne

    Page :AB12

    
  • ·A phase IV, open label study evaluating the use of minocycline HCl extended release tablets with topical bactericidal and antibiotic/retinoid preparations as a triple combination acne therapy for potential isotretinoin candidates

    Page :AB12

    
  • ·A single-center, prospective study on the efficacy and safety of microfocused ultrasound for the noninvasive treatment of moderate to severe facial acne

    Page :AB12

    
  • ·Acne and lifestyle: Results of a survey on a representative sample of the French population

    Page :AB13

    
  • ·Acne vulgaris in adult females: Racial differences in clinical characteristics, perceptions, and behaviors relevant to facial acne

    Page :AB13

    
  • ·An advance in comprehensive “real world” assessment of both the comedogenicity and acnegenicity of sunscreens in acne-prone consumers

    Page :AB13

    
  • ·Characterization of patients with elevated lipid levels taking isotretinoin

    Page :AB13

    
  • ·Cross-study comparison of efficacy and safety of clindamycin 1%/tretinoin 0.025% and adapalene 0.1%/benzoyl peroxide 2.5% for acne vulgaris

    Page :AB14

    
  • ·Double-blind, placebo-controlled study assessing the effect of chocolate consumption in subjects with a history of acne vulgaris

    Page :AB14

    
  • ·Efficacy and safety of a novel sonic brush head designed for cleansing acneic skin

    Page :AB14

    
  • ·Efficacy and safety of novel clindamycin 1%/tretinoin 0.025% formulation for acne vulgaris: Pooled analysis of 3 phase III studies

    Page :AB14

    
  • ·Efficacy and safety of once-daily brimonidine tartrate gel 0.5% for moderate to severe facial erythema of rosacea: Two randomized, double-blind, and vehicle-controlled phase III studies

    Page :AB15

    
  • ·Evaluating clinical trial design: Systematic review of randomized vehicle-controlled trials for determining efficacy of benzoyl peroxide topical therapy for acne

    Page :AB15

    
  • ·Ex vivo demonstration of a synergistic effect of adapalene and benzoyl peroxide on inflammatory acne lesions

    Page :AB15

    
  • ·Gene expression data provides evidence that decylene glycol can beneficially affect acne and normalize responses of keratinocytes to bacteria

    Page :AB15

    
  • ·How strong is the evidence linking a high glycemic index diet and obesity with acne?

    Page :AB16

    
  • ·Is the severity and persistence of acne “programmed” before puberty?

    Page :AB16

    
  • ·Modulating vascular inflammation and immune immunity in rosacea

    Page :AB16

    
  • ·More is less: Topical dermatologic product nonadherence in acne: An observational study

    Page :AB16

    
  • ·Natural modulation of PAR-2 and TLR2: Application to clinical acne skin care

    Page :AB17

    
  • ·Onset of action and efficacy of novel clindamycin 1%/tretinoin 0.025% formulation for acne vulgaris

    Page :AB17

    
  • ·Patient satisfaction with a fixed dose combination of adapalene-benzoyl peroxide gel as part of a regimen and used alone as maintenance therapy

    Page :AB17

    
  • ·Photodynamic therapy with methylaminolevulinate 80 mg/g and red light demonstrates significant efficacy in acne

    Page :AB17

    
  • ·Randomized controlled trial examining effectiveness of a novel personalized interactive health care education tool for acne patients (MyPACE)

    Page :AB18

    
  • ·Regulation of lipid production by acetylcholine signaling in human sebaceous glands

    Page :AB18

    
  • ·The clinical and histologic effect of home-use, combination blue-red LED phototherapy for mild to moderate acne vulgaris in Korean patients: A double-blind, randomized, sham device controlled trial

    Page :AB18

    
  • ·Tolerability, performance, and cosmetic acceptability of a foaming facial wash and facial moisturizer with SPF 30 in subjects on acne treatment

    Page :AB18

    
  • ·Treatment of acne in children aged 9 to 11 with a fixed dose combination of adapalene-benzoyl peroxide gel

    Page :AB19

    
  • ·Treatment of acne scars using a 1450-nm diode lasers

    Page :AB19

    
  • ·Treatment with adapalene-benzoyl peroxide improve quality of life in patients with severe acne vulgaris

    Page :AB19

    

• Aesthetic Dermatology

  • ·A comparison of the efficacy and safety of incobotulinum toxin A and onabotulinum toxin A in subjects with periocular rhytides and masseteric hypertrophy

    Page :AB19

    
  • ·A multicenter, double-masked, placebo-controlled study assessing patient satisfaction with bimatoprost ophthalmic solution 0.03% for increasing eyelash prominence

    Page :AB20

    
  • ·A multicenter, randomized, placebo-controlled study to evaluate the efficacy and safety of repeat treatments of crow's feet lines and glabellar lines with onabotulinumtoxina

    Page :AB20

    
  • ·A new 2-step topical line filler improves the appearance of glabellar lines, nasolabial folds, and crow's feet in a randomized, vehicle-controlled trial

    Page :AB20

    
  • ·A pilot study of a novel noninvasive topical under-eye contouring technology

    Page :AB20

    
  • ·A single-center, prospective study on the efficacy of the of microfocused ultrasound for the noninvasive treatment of skin wrinkles above the elbow

    Page :AB21

    
  • ·Adverse events of botulinum toxin injection: A multidepartment, retrospective study of 5653 treatments for 1826 patients experiences

    Page :AB21

    
  • ·Antiaging effect of lipohydroxy acid and xylopyranoside derivative combination

    Page :AB21

    
  • ·Application of phenolic acids in gels: New antioxidants perspective for antiaging effect

    Page :AB21

    
  • ·ATX-101 for the reduction of double chin caused by submental fat: Results from the ATX-101-10-16 European phase III study

    Page :AB22

    
  • ·Clinical overview on the efficacy and safety of a self-occlusive topical anesthetic cream containing lidocaine and tetracaine

    Page :AB22

    
  • ·Comparative study of the efficacy and tolerability of a unique topical scar product versus white petrolatum following shave biopsies

    Page :AB22

    
  • ·Complication of light sources: How to prevent and rectify in darker skin

    Page :AB22

    
  • ·CosmeceutiQoL: A dermocosmetic quality-of-life assessment tool

    Page :AB23

    
  • ·Efficacy and safety of eye serums formulated for use with a sonic applicator

    Page :AB23

    
  • ·Efficacy and safety of lipohydroxy acid combined with trichloracetic acid facial peel

    Page :AB23

    
  • ·Efficacy of a new lightening skin care routine on facial hyperpigmentation versus 1 intense pulsed laser (IPL) therapy

    Page :AB23

    
  • ·Excimer light for vitiligo and psoriasis: Number of session or cumulative dose, which is important?

    Page :AB24

    
  • ·Fashions change but tattoos are forever: Time to regret

    Page :AB24

    
  • ·In vivo reflectance confocal microscopy: A novel analytical technique for clinical efficacy assessment of skin brightening

    Page :AB24

    
  • ·Infraorbital rejuvenation using PRP (platelet-rich plasma): A prospective, randomized, split-face trial

    Page :AB24

    
  • ·Open label study of 1% retinol and double-blind placebo-controlled study of 0.5% retinol both in an oil-free aqueous protein rich suspension

    Page :AB25

    
  • ·Photodynamic therapy with methylaminolevulinate (MAL) for the treatment of photoaging

    Page :AB25

    
  • ·Reduction of double chin caused by submental fat with ATX-101: Results from the ATX-101-10-17 European phase III study

    Page :AB25

    
  • ·Tolerability and effect of facial subcutaneous injection of new dextran filler to the nasolabial folds: Multicenter, single blinded, single-arm, 24-week follow-up study

    Page :AB25

    
  • ·Tolerability and safety of a pseudoceramide-containing water in oil cream among diabetic patients

    Page :AB26

    
  • ·Use of combination therapy fractionated microneedle radiofrequency with fractional CO₂ laser for the treatment of striae distensae in Korean patients

    Page :AB26

    

• Aging/Geriatrics

  • ·A clinical evaluation of topical formulations containing a NF-κB inhibitor for improving photoaged skin

    Page :AB26

    
  • ·A cosmetic multiproduct regimen effectively reduces the appearance of facial hyperpigmentation

    Page :AB26

    
  • ·A double-blind, vehicle-controlled, 1-year clinical study of an antiaging technology for topical application to the face

    Page :AB27

    
  • ·Ability of topical 5% niacinamide to reduce ultraviolet light–induced erythema, barrier disruption, and inflammation

    Page :AB27

    
  • ·Age-dependent differences in epidermal stem cells and the effects of natural cosmetic ingredients assessed in human skin equivalent cultures

    Page :AB27

    
  • ·An in silico approach to identification of pathways involved in dermal aging aimed at antiaging intervention

    Page :AB27

    
  • ·Antiaging skin care formulation with antiglycation technology and stabilized retinol reduces fine lines and deep wrinkles in a human clinical study

    Page :AB28

    
  • ·Appearance of uneven facial texture is improved by a facial moisturizer containing cosmetic ingredients that boost cellular energy

    Page :AB28

    
  • ·Assessment of niacinamide in vivo skin penetration from a cosmetic moisturizer formula

    Page :AB28

    
  • ·Clinical assessment of efficacy and safety of a night cream containing vitamin C in facial photoaging

    Page :AB28

    
  • ·Epidemiologic analysis of eyelash characteristics with increasing age in a population of healthy women

    Page :AB29

    
  • ·Evaluation of the role of dermatopontin in skin aging by changing skin viscoelastic properties: In vivo study

    Page :AB29

    
  • ·Evidence that an olive derivative can beneficially affect intrinsic aging, photoaging, and inflammatory skin conditions based on gene expression profiling and pattern matching

    Page :AB29

    
  • ·Expression profiles of cholesterol biosynthetic pathway associated with skin intrinsic and extrinsic aging

    Page :AB29

    
  • ·Impact of oxidative stress on cellular bioenergetics in older aged fibroblasts: Ability of niacinamide to prevent and restore metabolic pathway efficiency and energy production

    Page :AB30

    
  • ·Improved appearance of facial wrinkles with use of a cosmetic moisturizer containing olive derivative, dill seed extract, Pal-KTTKS, and niacinamide

    Page :AB30

    
  • ·Improved appearance of facial wrinkles with use of a cosmetic moisturizer containing retinyl propionate, peptides, and niacinamide

    Page :AB30

    
  • ·Improvement in facial skin appearance by a cosmetic treatment regimen: A case study in identical twins

    Page :AB30

    
  • ·In vitro skin structure benefits produced by an olive derivative

    Page :AB31

    
  • ·In vivo benefits of a compound that modulates basal epidermal niche components during aging or following solar stress

    Page :AB31

    
  • ·Long term efficacy after use of a sonic applicator using a variety of commercially available eye products

    Page :AB31

    
  • ·Modulating shelterin components at telomere end exhibits antiaging effects: In vivo study

    Page :AB31

    
  • ·Quantification and visualization of cellular NADP(H) as a skin cell energy biomarker with in vivo 2-photon tomography

    Page :AB32

    
  • ·Skin bioenergy and antiaging responses to a complex of cosmetic ingredients with dill seed extract

    Page :AB32

    
  • ·Skin biomarkers confirm skin antioxidant activity of an olive derivative

    Page :AB32

    

• Arts, History, and Humanities of Dermatology

  • ·An exploration of how culture plays a role in one's perception of acne

    Page :AB32

    
  • ·Dermatologic art critiques: From the Louvre museum and more

    Page :AB33

    
  • ·Female Scottish doctors on the Western Front (1916-1918) and an overlooked revolution in treatment for clostridial myonecrosis

    Page :AB33

    
  • ·From home remedy to cancer treatment: A history of ingenol mebutate and euphorbia peplus in dermatology

    Page :AB33

    
  • ·Photography for the practicing dermatologist

    Page :AB33

    
  • ·The history of sunscreen

    Page :AB34

    
  • ·Trends in body hair removal as depicted through art

    Page :AB34

    
  • ·Violet ray generators: Their historical use in dermatology

    Page :AB34

    

• Basic Science

  • ·How to kill a kinase: Possible mechanism for irreversible conformational change of the BRAF kinase domian and BRAF/KSR1 kinase heterodimer salt-bridge “cluster” distortion

    Page :AB34

    
  • ·A natural biotechnologic active ingredient dedicated to skin trouble management

    Page :AB35

    
  • ·Antimycotic activity and penetration through bovine hoof membranes of an innovative terbinafine nail solution (P-3058)

    Page :AB35

    
  • ·Delivery of stearic acid to scalp stratum corneum from zinc pyrithione shampoo

    Page :AB35

    
  • ·Dermatologic assessment of the skin tolerance of a daily shave with a 5-blade razor for men with sensitive skin

    Page :AB35

    
  • ·Down-regulation of type I collagen expression in silibinin-treated human skin fibroblasts through blocking Smad2/3-dependent signaling pathway: Its potential therapeutic use in the chemoprevention of keloid

    Page :AB36

    
  • ·Evidence from gene-expression profiling of the inhibition by niacinamide of both innate and adaptive immune response processes and pathways associated with skin photoaging

    Page :AB36

    
  • ·In vivo laser speckle measurement of skin roughness versus profilometric measurement of silicone replicas

    Page :AB36

    
  • ·Persistence of corneodesmosomes and elevation of protease inhibitors LEKTI and SCCA1 in dandruff

    Page :AB36

    
  • ·Relationship of cutaneous moisture, pH, and sebum levels with menstrual cycle

    Page :AB37

    
  • ·Role of melanocyte proteasome in melanin production

    Page :AB37

    
  • ·Skin barrier protection with jojoba esters

    Page :AB37

    
  • ·The function of a novel immunoglobulin protein MPZL3 in the skin

    Page :AB37

    

• Clinical Dermatology and Other Cutaneous Disorders

  • ·Vibration plate purpura: A new lifestyle dermatosis

    Page :AB38

    
  • ·Tacrolimus ointment 0.1% in the treatment of scrotal lichen simplex chronicus: An open-label study

    Page :AB38

    
  • ·A case of cutaneous metastases from multiple myeloma

    Page :AB38

    
  • ·A case of cutaneous Rosai–Dorfman disease

    Page :AB38

    
  • ·A case of disseminated cutaneous miliarial gout

    Page :AB39

    
  • ·A case of generalized atypical pyoderma gangrenosum mimicking Sweet syndrome

    Page :AB39

    
  • ·A case of migratory panniculitis

    Page :AB39

    
  • ·A case of pseudolympoma caused by therapy with medicinal leeches

    Page :AB39

    
  • ·A new aluminum sesquichlorhydrate topical foam for the treatment of axillary and/or palmar primary hyperhidrosis: A preliminary report

    Page :AB40

    
  • ·A novel hidradenitis suppurativa efficacy variable, HiSCR (hidradenitis suppurativa clinical response), is responsive to change with adalimumab therapy: Results of a phase II study

    Page :AB40

    
  • ·A rare presentation of a pilomatrixoma: A bullous variant

    Page :AB40

    
  • ·A rare variant of Sweet syndrome: A consequence of adalimumab therapy?

    Page :AB40

    
  • ·A reliable and relevant method for assessing dandruff product efficacy based on the adherent scalp flaking score (ASFS)

    Page :AB41

    
  • ·Abdominal metastasis of papillary thyroid cancer

    Page :AB41

    
  • ·Acitretin-refractory oral, esophageal, and cutaneous lichen ruber planus controlled with alitretinoin

    Page :AB41

    
  • ·Acute generalized exanthematous pustules induced by overdose of oral acetaminophen for suicide attempt

    Page :AB41

    
  • ·Acute polyarticular synovitis as a rare presentation of Kaposi sarcoma

    Page :AB42

    
  • ·An atypical case of disseminated visceral leishmaniasis/HIV coinfection widely involving the skin

    Page :AB42

    
  • ·An atypical distribution of erythema elevatum diutinum

    Page :AB42

    
  • ·An atypical plaque-like giant dermatofibroma

    Page :AB42

    
  • ·An investigator-initiated study to assess the safety and efficacy of imiquimod 3.75% cream when used after cryotherapy in the treatment of hypertrophic actinic keratoses on dorsal hands and forearms

    Page :AB43

    
  • ·An itchy eruption in 3 patients with hematologic malignancy

    Page :AB43

    
  • ·An unusual foreign body in the penis: Transurethral extrusion of penile prosthesis

    Page :AB43

    
  • ·Anetoderma and aging skin face

    Page :AB43

    
  • ·Angiolymphoid hyperplasia with eosinophilia (ALHE): Histology, dermatoscopic features, and management

    Page :AB44

    
  • ·Atypical presentation of hidradenitis suppurativa: A case report and review of the literature

    Page :AB44

    
  • ·Autoimmune progesterone dermatitis associated with β-HCG diet drug

    Page :AB44

    
  • ·Azathioprine hypersensitivity presenting as neutrophilic dermatosis and erythema nodosum

    Page :AB44

    
  • ·Cardiac arrest and dilated cardiomyopathy in a patient with epidermolysis bullosa simplex and hidradenitis suppurativa

    Page :AB45

    
  • ·Ashy dermatosis

    Page :AB45

    
  • ·Circumscribed palmar hypokeratosis: One case and review

    Page :AB45

    
  • ·Clinical exuberance of cutaneous sarcoidosis: Case report

    Page :AB45

    
  • ·Comorbidities are common among patients with moderate-to-severe hidradenitis suppurativa; depression and morbid obesity are positively associated with disease severity

    Page :AB46

    
  • ·Comparative evaluation of antidandruff clinical efficacy of a potentiated zinc pyrithione shampoo and a zinc pyrithione/climbazole combination formula

    Page :AB46

    
  • ·Comparative study of syphilid and syphilid-like eruption on the palms

    Page :AB46

    
  • ·Congenital multiple clustered dermatofibroma and multiple eruptive dermatofibromas: Exceedingly rare presentations of a common entity

    Page :AB46

    
  • ·Cutaneous sarcoidosis triggered by immunotherapy for chronic hepatitis C: A case report

    Page :AB47

    
  • ·Dermal hypersensitivity reaction preceding eosinophilic fasciitis

    Page :AB47

    
  • ·Dermatoscopy of cutaneous angiosarcoma of the scalp showing various color gradations

    Page :AB47

    
  • ·Development of an artificial sebum methodology to evaluate efficacy of facial cleansers

    Page :AB47

    
  • ·Diffuse cutaneous Langerhans cell histiocytosis: Multitherapy resistant with response to acitretin and treatment with isotretinoin

    Page :AB48

    
  • ·Digital dermatofibroma: Common lesion, uncommon site

    Page :AB48

    
  • ·Economic burden of hidradenitis suppurativa after a single surgical intervention: Assessment of unmet needs using a retrospective claims-based analysis

    Page :AB48

    
  • ·Effect of everolimus, an oral mtor inhibitor, on angiogenic biomarkers in patients with tuberous sclerosis complex (TSC) and skin lesions

    Page :AB48

    
  • ·Efficacy and safety of a sonic skin care brush on keratosis pilaris

    Page :AB49

    
  • ·Efficacy and safety of adalimumab treatment in women with moderate to severe hidradenitis suppurativa: Analysis from the placebo-controlled portion of a phase II, randomized, double-blind study

    Page :AB49

    
  • ·Efficacy of an oatmeal and petrolatum skin protectant ointment in improving skin barrier properties in abraded skin and moderate to severely dry skin

    Page :AB49

    
  • ·Efficient treatment of idiopathic chronic cold urticaria with omalizumab: Report of 3 cases and a review of the literature

    Page :AB49

    
  • ·Epidermodysplasia verruciformis associated with HPV 10

    Page :AB50

    
  • ·Eruptive collagenomas of the skin in an adult woman

    Page :AB50

    
  • ·Erythema elevatum diutinum

    Page :AB50

    
  • ·Erythema elevatum diutinum in a 32-year-old pregnant woman

    Page :AB50

    
  • ·Familial eruptive sebaceous hyperplasia responded to oral isotretinoin

    Page :AB51

    
  • ·First case of oral verruciform xanthoma associated with dyskeratosis congenita

    Page :AB51

    
  • ·Fixed drug eruption triggered by fluconazole mimicking herpes labialis

    Page :AB51

    
  • ·Frontal fibrosing alopecia associated with lichen planus pigmentosum

    Page :AB51

    
  • ·Fumaric acid esters to treat psoriasis: Experience in a UK teaching hospital

    Page :AB52

    
  • ·Generalized and very itchy skin lesions after starting a treatment with enalapril

    Page :AB52

    
  • ·Granuloma annulare of the penis

    Page :AB52

    
  • ·Histiocytic inflammation induced by granulocyte-macrophage colony–stimulating factors

    Page :AB52

    
  • ·Incobotulinumtoxin A in the treatment of hyperfunctional facial lines: Evaluation of patient self-perception and physical appearance

    Page :AB53

    
  • ·Infliximab treatment for refractory cutaneous sarcoidosis: Experience from a tertiary referral center

    Page :AB53

    
  • ·Juvenile xanthogranuloma in an adult male

    Page :AB53

    
  • ·Langerhans cell histiocytosis: Treatment of cutaneous disease with azathioprine

    Page :AB53

    
  • ·Leishmaniosis in the countryside of São Paulo (Brazil)

    Page :AB54

    
  • ·Lichen planus pigmentosus-inversus: Two case reports and clinical review

    Page :AB54

    
  • ·Long-standing keratoses on the palms and soles

    Page :AB54

    
  • ·Lupus and scleroderma overlap: Defining the patterns of evolution

    Page :AB54

    
  • ·Necrobiosis lipoidica

    Page :AB55

    
  • ·Nefrogenic fifrosing dermopathy: Rare cutaneous fibrosing disorder

    Page :AB55

    
  • ·Neuro-Sweet syndrome responds to hydroxychloroquine

    Page :AB55

    
  • ·Nevus oligemicus on the breasts

    Page :AB55

    
  • ·Nicolau Balus syndrome with microcystic adnexal carcinoma

    Page :AB56

    
  • ·Nodular amyloidosis: Clinical recognition of an unusual entity

    Page :AB56

    
  • ·Paraneoplastic cutaneous vasculitis in multiple myeloma

    Page :AB56

    
  • ·Patch test with dental screening series in oral disease

    Page :AB56

    
  • ·Patient with subcorneal pustular dermatosis: Sneddon–Wilkinson syndrome

    Page :AB57

    
  • ·Patients’ experiences with hidradenitis suppurativa: A qualitative study of symptoms and impacts

    Page :AB57

    
  • ·Pityriasis rubra pilaris and arthritis: Is there a link?

    Page :AB57

    
  • ·Plantar lichen sclerosus et atrophicus

    Page :AB57

    
  • ·Poroma of the forehead and face: Not so uncommon presentations of a rare lesion

    Page :AB58

    
  • ·Postmenopausal craniofacial hyperhidrosis

    Page :AB58

    
  • ·Pregnancy-associated hyperkeratosis of the nipple: A study of 25 cases

    Page :AB58

    
  • ·Prevalence and incidence of hidradenitis suppurativa in the United States: Evidence from large administrative claims databases

    Page :AB58

    
  • ·Primary cutaneous endometriosis

    Page :AB59

    
  • ·Primary cutaneous nodular amyloidosis: A case study and overview of systemic evaluation

    Page :AB59

    
  • ·Primary systemic amyloidosis treated with autologous stem cell transplant and chemotherapy

    Page :AB59

    
  • ·Randomized, double-blind, controlled pilot study of the efficacy and safety of microfocused ultrasound for the treatment of axillary hyperhidrosis

    Page :AB59

    
  • ·Rare cutaneous presentation of IgG4 related disease: A case report

    Page :AB60

    
  • ·Recalcitrant interstitial granulomatous-like variant of scleromyxedema responding to intravenous immunoglobulin therapy

    Page :AB60

    
  • ·Recalcitrant seborrhoeide in an atopic female successfully treated with oral acitretin

    Page :AB60

    
  • ·Recurrence of lepromatous leprosy in a patient with intolerance of dapsone

    Page :AB60

    
  • ·Retrospective analysis of management of patients with hyperhidrosis in a general dermatology clinic over a 6-year period

    Page :AB61

    
  • ·Review of cases presented to a drug eruption clinic at a tertiary dermatology centre in Singapore

    Page :AB61

    
  • ·Risk of pruritus in cancer patients treated with cetuximab: A systematic review of the literature and metaanalysis

    Page :AB61

    
  • ·Risk of pruritus in cancer patients treated with inhibitors of the mammalian target of rapamycin, everolimus and temsirolimus: A systematic review of the literature and metaanalysis

    Page :AB61

    
  • ·Rosacea in skin of color

    Page :AB62

    
  • ·Safety and efficacy of human fibroblast lysate cream for provoked localized vulvodynia

    Page :AB62

    
  • ·Safety and efficacy of human fibroblast lysate cream for vulvar lichen sclerosus

    Page :AB62

    
  • ·Scalp sarcoidosis: A beacon of systemic sarcoidosis

    Page :AB62

    
  • ·Schamberg disease with plantar involvement

    Page :AB63

    
  • ·Self-healing Langerhans cell histiocitosis in an adult

    Page :AB63

    
  • ·Severely recalcitrant pyoderma gangrenosum successfully treated with ustekinumab

    Page :AB63

    
  • ·Significant protection from event stress—without a prescription

    Page :AB63

    
  • ·Simultaneous Sweet syndrome and cutaneous vasculitis after varicella

    Page :AB64

    
  • ·Some useful dermatoscopic features in a general dermatologic setting

    Page :AB64

    
  • ·Subcutaneous nodules related to acupoint catgut-embedding therapy for obesity

    Page :AB64

    
  • ·Successful treatment of recalcitrant disseminated granuloma annulare with minocycline, ofloxacin, and rifampin combination therapy

    Page :AB64

    
  • ·Sweet syndrome

    Page :AB65

    
  • ·The aerobic bacterial culture and antibiotic susceptibility of epidermal cysts in Korea

    Page :AB65

    
  • ·The impact of gender and ethnicity on therapeutic efficacy of antidandruff products

    Page :AB65

    
  • ·The Mayo Clinic experience with otic lichen planus: A 10-year review

    Page :AB65

    
  • ·The new ultrasound technology for hyperhidrosis treatment: Two case reports

    Page :AB66

    
  • ·Tolerance of facial cleansers on adults with clinically sensitive skin

    Page :AB66

    
  • ·Tolerance of facial cleansers with and without fragrance in fragrance-sensitive adults

    Page :AB66

    
  • ·Tracion alopecia simulating lichen planopilaris

    Page :AB66

    
  • ·Treatment of rosacea with photodynamic therapy: Case report and literature review

    Page :AB67

    
  • ·Two children with persistent, pruritic injection site nodules after receiving vaccinations which contained aluminium

    Page :AB67

    
  • ·Unusual applications of dermatoscopy

    Page :AB67

    
  • ·Unusual presentation of cutaneous neurofibroma: A case report

    Page :AB67

    
  • ·Validation of the hidradenitis suppurativa clinical response as a clinical endpoint for hidradenitis suppurativa treatment evaluation

    Page :AB68

    
  • ·Verrucous and cuniculatum carcinomas as complication of chronic verrucous lichen planus

    Page :AB68

    
  • ·Vitamin D and skin hydration

    Page :AB68

    
  • ·Worsening of keloids after intralesional injections

    Page :AB68

    

• Connective Tissue Diseases

  • ·A case of scleroderma with myocarditis presenting as acute heart failure

    Page :AB69

    
  • ·Annular elastolytic giant cell granuloma: Case report and treatment with dapsone

    Page :AB69

    
  • ·Bilateral periorbital edema: Debut of systemic lupus erythematosus

    Page :AB69

    
  • ·Coexistence of linear scleroderma and systemic sclerosis

    Page :AB69

    
  • ·Cutaneous ulceration: More than skin deep?

    Page :AB70

    
  • ·Hydroxyurea-induced dermatomyositis-like eruption with abnormal expression of p53

    Page :AB70

    
  • ·Hypomyopathic dermatomyositis with antibodies to MDA5 presenting with severe cardiomyopathy

    Page :AB70

    
  • ·Incidence of discoid lupus erythematosus without systemic lupus: Data from the Georgia lupus registry

    Page :AB71

    
  • ·Isolated collagenoma of the scalp resembling cutis verticis gyrata

    Page :AB71

    
  • ·Lupus erythematosus tumidus: A case report of difficult clinical individualization

    Page :AB71

    
  • ·Morpheaform reaction caused by interferon-beta 1b

    Page :AB71

    
  • ·Simultaneous occurrence of subacute cutaneous lupus erythematosus and Sweet syndrome–like neutrophilic dermatosis: Case report and review of the literature

    Page :AB72

    
  • ·Sjögren syndrome–associated localized cutaneous nodular amyloidosis

    Page :AB72

    
  • ·Systemic sclerosis after silicone injections for facial cosmetic surgery

    Page :AB72

    
  • ·Toxic epidermal necrolysis–like lesions associated with lupus erythematosus: A report of 2 cases

    Page :AB72

    
  • ·Treatment of cutaneous dystrophic calcification with intralesional sodium thiosulfate

    Page :AB73

    

• Dermatitis, Atopic

  • ·A colloidal oatmeal OTC cream is as clinically effective as a prescription barrier repair cream for the management of mild to moderate atopic dermatitis in African American children

    Page :AB73

    
  • ·A new methodology to map the relative mildness potential of personal cleansing products

    Page :AB73

    
  • ·A validation of a novel technology in body wash for consumer preferred sensories with ultramild surfactants and effective skin conditioning

    Page :AB73

    
  • ·An ethnographic insight into the psychological impact of hand eczema

    Page :AB74

    
  • ·Analysis of emergency department admissions for atopic dermatitis at a busy urban children's hospital: 4 years later

    Page :AB74

    
  • ·Antiitching and barrier restoring effects of a lipid-replenishing balm on atopic dermatitis models

    Page :AB74

    
  • ·Children with atopic dermatitis: Monitoring a French cohort over a 9-year period

    Page :AB74

    
  • ·Clinical evaluation of pseudoceramide-containing water-in-oil cream among atopic eczema patients

    Page :AB75

    
  • ·Correlation between the amount of topical agent and severity in atopic dermatitis

    Page :AB75

    
  • ·Cosmetic acceptability of licensed emollients: An in vivo comparison of 2 commercially available products, DELP gel and DIPC cream

    Page :AB75

    
  • ·Effect of environmentally friendly wallpaper and flooring material on indoor air quality and atopic dermatitis

    Page :AB75

    
  • ·Efficacy of house dust mite–specific immunotherapy in patients with atopic dermatitis

    Page :AB76

    
  • ·Epidemiologic profile of a cohort of atopic dermatitis in Rio de Janeiro, Brazil

    Page :AB76

    
  • ·Evaluation of patient experience of atopic dermatitis with a view of assessing whether life course impairment is cumulative

    Page :AB76

    
  • ·HAT-01, a novel herbal preparation, is superior to corticosteroids and pimecrolimus for the treatment of moderate to severe atopic dermatitis

    Page :AB76

    
  • ·Impact of water temperature and cleanser selection on skin condition

    Page :AB77

    
  • ·Improvement of skin barrier function in atopic dermatitis patients with a new moisturizer containing a ceramide precursor

    Page :AB77

    
  • ·Methotrexate-responsive endogenous eczema: A multicenter analysis of 41 patients

    Page :AB77

    
  • ·Novel use of a cooling pillow for treatment of severe head and neck atopic dermatitis

    Page :AB77

    
  • ·Psychosomatic evaluation of patients with atopic dermatitis

    Page :AB78

    
  • ·Relative roles of surfactant interactions with proteins and lipids in cleanser-induced skin dryness

    Page :AB78

    
  • ·Skin clusters and canyons: New insights from old structures

    Page :AB78

    
  • ·Stratum corneum fatty acids: Their critical role in preserving barrier integrity during cleansing

    Page :AB78

    
  • ·The burden imposed by atopic dermatitis on families: Creation of a specific questionnaire

    Page :AB79

    
  • ·Use of in vitro methods to quantify the ability of moisturizing products to hydrate skin and provide a water vapor barrier: Development of a moisturization index for persons with atopic dermatitis

    Page :AB79

    

• Dermatitis, Contact, Allergic and Irritant

  • ·A global patch test grader training program

    Page :AB79

    
  • ·Alitretinoin: A new systemic treatment in the management of chronic hand eczema

    Page :AB79

    
  • ·Allergic contact dermatitis: Clinicopathologic correlation of the expression of interleukin-17 and neutrophil elastase at 48 hours of exposure to allergens

    Page :AB80

    
  • ·Clinical considerations on the use of alitretinoin

    Page :AB80

    
  • ·Comparative efficacy and safety of azathioprine versus methotrexate as steroid-sparing agent in the treatment of airborne contact dermatitis caused by parthenium

    Page :AB80

    
  • ·Comparison of therapeutic effectiveness of weekly azathioprine pulse and daily azathioprine in treatment of parthenium dermatitis

    Page :AB80

    
  • ·Complete response to large-field external beam radiation therapy for severe, extensive dermatitis

    Page :AB81

    
  • ·Cutaneous metal reaction from titanium plate: A case report

    Page :AB81

    
  • ·Diagnosis and prevalence of lanolin allergy: A prospective study

    Page :AB81

    
  • ·Emerging role of water in the etiopathogenesis of SNAS: Comparative study between Rome and Baltimore

    Page :AB81

    
  • ·Mesotherapy granulomas with L-carnitine

    Page :AB82

    
  • ·Modified stinging test: New tolerance predictive test for baby products

    Page :AB82

    
  • ·New nursing uniforms cause skin symptoms in over half of wearers

    Page :AB82

    
  • ·Patch testing in patients with vulval dermatoses: Changing allergen frequency over 7 years

    Page :AB82

    
  • ·Prognosis of contact allergy against aluminum induced by vaccination with aluminum adsorbed vaccines

    Page :AB83

    
  • ·Pseudotumor formation caused by delayed hypersensitivity to metal release from metal-on-polyethylene hip replacement

    Page :AB83

    
  • ·Stevens–Johnson syndrome associated with TS-1

    Page :AB83

    
  • ·Sulfur spring dermatitis

    Page :AB84

    
  • ·Two cases of allergic contact dermatitis caused by rubber additives of unusual origin

    Page :AB84

    
  • ·Use of allopurinol for the treatment of the reaction to red tattoo pigments: Case report

    Page :AB84

    

• Dermatopathology

  • ·A case of multinucleate cell angiohistiocytoma

    Page :AB84

    
  • ·A unique case of extralesional mucin deposition in a patient with eruptive myxoid dermatofibromata

    Page :AB85

    
  • ·An agressive rapidly enlarging nodule

    Page :AB85

    
  • ·Clinicopathologic study of erythroderma

    Page :AB85

    
  • ·Epithelial sheath neuroma mimicking perineural invasion of a dysplastic nevus

    Page :AB85

    
  • ·Granulomatous variant of scleromyxedema mimicking a drug reaction

    Page :AB86

    
  • ·Histiocytoid Sweet syndrome in a patient with myelofibrosis dominant myelodysplastic syndrome

    Page :AB86

    
  • ·Hyperpigmentation associated with intradermal tranexamic acid injections for treatment of melasma

    Page :AB86

    
  • ·Immunohistochemical staining in cutaneous marginal zone B-cell lymphoma

    Page :AB86

    
  • ·Multinucleate cell angiohistiocytoma

    Page :AB87

    
  • ·Necrotising infundibular crystalline folliculitis

    Page :AB87

    
  • ·Scleroderma-like reaction to red tattoo ink

    Page :AB87

    
  • ·Seasonal variation in the incidence of lichen planus–like keratosis

    Page :AB87

    
  • ·Squamoid eccrine ductal carcinoma: A rare adnexal tumor

    Page :AB88

    
  • ·Superficial acral fibromyxoma of the great toe

    Page :AB88

    
  • ·The merits of using alternate staining with toluidine blue and hematoxylin–eosin during Mohs micrographic surgery for basal cell carcinomas

    Page :AB88

    

• Digital/Electronic Technology

  • ·A mobile dermatology platform for patient care

    Page :AB88

    
  • ·A novel smartphone technology to facilitate collaboration and discussion in patient care

    Page :AB89

    
  • ·Development of quantitative assessment method of pigmentary skin disease using ultraviolet optical imaging system

    Page :AB89

    
  • ·Hidradenitis suppurativa: Patient experiences with bariatric surgery

    Page :AB89

    
  • ·Patient satisfaction with a novel, patient-centered model for psoriasis follow-up care: Results from a randomized controlled trial

    Page :AB89

    
  • ·The relationship between dermatopathologic features and the color of skin lesion in various rashes

    Page :AB90

    
  • ·There's an app for that: The emergence of mobile applications in dermatology

    Page :AB90

    
  • ·Use of electronic medical records differs by specialty and office settings

    Page :AB90

    

• Education and Community Service

  • ·Playing with fire: Decrease in safe sex attitudes among men who have sex with men in a Portuguese sexually transmitted infections clinic

    Page :AB90

    
  • ·Are dermatology residents adequately prepared for the business of medicine?

    Page :AB91

    
  • ·Dermatologic needs of an underserved patient population

    Page :AB91

    
  • ·Dermpedia.org: An online project created to advance the field of dermatology by organizing the knowledge and experience acquired by clinicians worldwide

    Page :AB91

    
  • ·Efficacy of a multimodality curriculum in a pigmented lesion clinic to teach dermatoscopy to dermatology residents

    Page :AB91

    
  • ·Evaluation of a novel mechanism of transcultural graduate medical education: Global Grand Rounds

    Page :AB92

    
  • ·Knowledge is not power, self-esteem is

    Page :AB92

    
  • ·Skin cancer awareness in white Hispanics and non-Hispanic whites

    Page :AB92

    
  • ·SkinSafe: An evaluation of the long-term impact of a province-wide sun safety and skin cancer high school education campaign

    Page :AB92

    

• Epidemiology and Health Services Administration

  • ·A web-based approach to melanoma education aimed at the Hispanic population improves knowledge and behaviors

    Page :AB93

    
  • ·A year of dermatology adult hospital consultations

    Page :AB93

    
  • ·Ambulatory care visits for itch in the United States 1999-2009

    Page :AB93

    
  • ·An observation of Taiwan's health care system of clinical efficiency as a possible model for increased patient access to care and affordability

    Page :AB93

    
  • ·Common dermatology presentations in the emergency department: Who, what, and when

    Page :AB94

    
  • ·Dermatologic conditions in children adopted internationally

    Page :AB94

    
  • ·Dermatologic inpatient consultations in a general university hospital

    Page :AB94

    
  • ·Identifying the patient with moderate psoriasis through 2 innovative tools: PsoDISK and Explora

    Page :AB94

    
  • ·Infantile hemangioma and risk factors: A literature review

    Page :AB95

    
  • ·Infantile hemangioma: Epidemiology update

    Page :AB95

    
  • ·Management of cutaneous abscess by dermatologists

    Page :AB95

    
  • ·Skin and climate

    Page :AB95

    
  • ·Skin disease as a presenting complaint to a pediatric emergency department

    Page :AB96

    
  • ·US children with erythematous conditions are more frequently critically ill and consume more health care resources than children hospitalized for other reasons

    Page :AB96

    

• Genodermatoses

  • ·A novel mutation in Gorlin–Goltz syndrome

    Page :AB96

    
  • ·Birt-Hogg-Dubé syndrome: Treatment of multiple fibrofolliculomas with hyfrecation

    Page :AB96

    
  • ·Buschke–Ollendorff syndrome mimicking pseudoxanthoma elasticum with a perforating disorder

    Page :AB97

    
  • ·Cardiofaciocutaneous syndrome with multiple cutaneous and perioral telangiectasia

    Page :AB97

    
  • ·Diffuse dermal angiomatosis and calciphylaxis-like changes in POEMS sydnrome

    Page :AB97

    
  • ·Epidermodysplasia verruciformis in a patient with AIDS

    Page :AB97

    
  • ·Histopathologic findings of microvascular occlusion syndromes

    Page :AB98

    
  • ·Human piebaldism

    Page :AB98

    
  • ·Identification of a novel ECM1 mutation in 2 siblings with lipoid proteinosis

    Page :AB98

    
  • ·IQoL: A new ichthyosis-specific measure of quality of life

    Page :AB98

    
  • ·Keratitis, congenital ichthyosis, and neurosensory deafness syndrome with tinea capitis and severe kerion formation

    Page :AB99

    
  • ·Loss of genomic DNA copy numbers in the p18, p16, p27, and RB loci in blastic plasmacytoid dendritic cell neoplasm

    Page :AB99

    
  • ·Multiple facial angiofibromas revealing Birt-Hogg-Dubé syndrome

    Page :AB99

    
  • ·Netherton syndrome in association with vitamin D deficiency

    Page :AB99

    
  • ·Patients with tuberous sclerosis complex and skin lesions: Results of a patient and caregiver survey in the United States

    Page :AB100

    
  • ·Pseudoxanthoma elasticum

    Page :AB100

    
  • ·Survival with 2 DNA repair disorders

    Page :AB100

    
  • ·Trichorhinophalangeal syndrome type I: Clinical and molecular features of a sporadic Asian patient

    Page :AB100

    

• Hair and Nail Disorders

  • ·A comparison among commonly used nail products on nail mechanical properties

    Page :AB101

    
  • ·A nodule in the toe: Case report of eccrine poroma

    Page :AB101

    
  • ·A phase II study of efinaconazole solution for the once-daily treatment of toenail onychomycosis: Primary efficacy assessment

    Page :AB101

    
  • ·A phase II study of efinaconazole solution for the once-daily treatment of toenail onychomycosis: Secondary efficacy assessment

    Page :AB102

    
  • ·Alarming trends toward clinical diagnosis and management of psoriatic nails in the general practitioners and nondermatologist specialists

    Page :AB102

    
  • ·An innovative terbinafine transungual solution (P-3058): Dose finding investigation on clinical benefit in patients affected by mild-to-moderate toe onychomycosis

    Page :AB102

    
  • ·Association between epidermal growth factor and epidermal growth factor receptor gene polymorphisms and susceptibility to alopecia areata in Korean population

    Page :AB103

    
  • ·Autologous platelet-rich plasma as a potential therapeutic tool in androgenetic alopecia

    Page :AB103

    
  • ·Becker nevus of the face with asymmetrical growth of beard hair

    Page :AB103

    
  • ·Cross-section trichometry, a clinical tool for assessing the progression and treatment response of alopecia

    Page :AB103

    
  • ·Development of an optimal formulation for efinaconazole a novel antifungal agent for the treatment of onychomycosis by topical application

    Page :AB104

    
  • ·Dissecting folliculitis

    Page :AB104

    
  • ·Effect of an innovative terbinafine nail solution (P-3058) on in vitro nail experimental infections

    Page :AB104

    
  • ·Efinaconazole 10% solution a new triazole antifungal developed for topical onychomycosis treatment: Nail penetration and systemic absorption

    Page :AB104

    
  • ·Efinaconazole 10% solution: Nonclinical safety supports topical use in onychomycosis

    Page :AB105

    
  • ·Evaluation of safety profile, pharmacokinetics, and clinical benefit of an innovative terbinafine transungual solution (P-3058): A phase I study in patients with mild-to-moderate distal subungual onychomycosis

    Page :AB105

    
  • ·Facial lichen planopilaris: An atypical presentation and review of a new variant

    Page :AB105

    
  • ·Follicular red dots in areas with an anatomic colocalization of alopecia areata and vitiligo

    Page :AB105

    
  • ·Hereditary leukonychia and koilonychia without associated findings

    Page :AB106

    
  • ·In vitro antifungal activity of efinaconazole, a novel triazole antifungal, against a variety of pathogenic fungi

    Page :AB106

    
  • ·In vitro evaluation of the potential of ciclopirox to induce resistance in Trichophyton rubrum, in comparison to terbinafine, amorolfine, and itraconazole

    Page :AB106

    
  • ·Incidence of alopecia areata in Olmsted County, Minnesota 1990-2009

    Page :AB106

    
  • ·Incidence of alopecia from endocrine therapies in cancer

    Page :AB107

    
  • ·Insulin resistance and hair disorders, idiopathic hirsutism, and androgenic alopecia

    Page :AB107

    
  • ·Minimal systemic exposure of a new topical triazole antifungal, efinaconazole 10% solution, in patients with severe onychomycosis following 28-day treatment

    Page :AB107

    
  • ·Onychomatricoma with classic features: Case report and review of the literature

    Page :AB107

    
  • ·Premature graying of scalp hairs treated with ferrous sulfate

    Page :AB108

    
  • ·Prevalance, clinical features and evaluation of the risk factors for onychocriptosis in adult diabetic patients in outpatient clinic

    Page :AB108

    
  • ·Single and repeated dose of finasteride topical solution in subjects with androgenetic alopecia: A pharmacokinetic and pharmacodynamic study

    Page :AB108

    
  • ·Sparse hair in a female toddler

    Page :AB108

    
  • ·Subungual spindle cell lipoma: Case report

    Page :AB109

    
  • ·Subungueal melanoma in a young patient: Case report

    Page :AB109

    
  • ·Terbinafine nail solutions for topical treatment of onychomycosis: Ex vivo study on penetration/retention through and into keratin membranes

    Page :AB109

    
  • ·The effect of a novel zinc pyrithione hair care system on female scalp condition

    Page :AB109

    
  • ·Toenail onychomatricoma: A differential diagnosis of melanonychia

    Page :AB110

    
  • ·Uncombable hair syndrome: A case presentation

    Page :AB110

    
  • ·Unique properties of efinaconazole 10% solution, a new topical treatment for onychomycosis

    Page :AB110

    

• Immunodermatology and Blistering Disorders

  • ·A case of epidermolysis bullosa acquisita treated with rituxmab with comparisons to other epidermolysis bullosa acquisita reports and pemphiguis

    Page :AB110

    
  • ·A distinct oral phenotype in immunoglobulin A predominant mucous membrane pemphigoid

    Page :AB111

    
  • ·A successful single-cycle rituximab treatment in radiation-induced pemphigus vulgaris with squamous cell carcinoma of the tongue and immunoglobulin G antibodies to desmocollins

    Page :AB111

    
  • ·An erythema multiforme–like presentation of Sweet syndrome

    Page :AB111

    
  • ·Bullous pemphigoid and dermatitis herpetiformis overlap

    Page :AB111

    
  • ·Case of subepidermal blistering disease in a 14-month-old infant

    Page :AB112

    
  • ·Drug-induced linear immunoglobulin A bullous dermatosis (drug associated) Vancomycin

    Page :AB112

    
  • ·Efficacy and safety of rituximab treatment in Indian pemphigus patients

    Page :AB112

    
  • ·Eosinophilic folliculitis successfully treated with intravenous immunoglobulin: Case report

    Page :AB112

    
  • ·Epitope spreading in pemphigus patients from São Paulo, Brazil: A 10-year follow-up

    Page :AB113

    
  • ·Erythema multiforme associated with the combined use of lamotrigine and cyclobenzaprine: A case report

    Page :AB113

    
  • ·Intravenous immunoglobulin for the treatment of quetiapin-induced bullous pemphigoid in an HIV-infected patient

    Page :AB113

    
  • ·Linear IgA bullous dermatosis herpeticum: Disseminated herpes simplex virus infection within the lesions of vancomycin-induced linear IgA bullous dermatosis

    Page :AB113

    
  • ·Ofloxacin-induced linear IgA dermatosis mimicking toxic epidermal necrolysis

    Page :AB114

    
  • ·Paraneoplastic pemphigus in an HIV-positive patient: First reported case

    Page :AB114

    
  • ·Paraneoplastic pemphigus: A case report

    Page :AB114

    
  • ·Pemphigoid gestationis: Debut in the third preganancy

    Page :AB114

    
  • ·Propylthiouracil-induced antineutrophil cytoplasmic antibody (anti-MPO and anti-PR3) positive leukocytoclastic vasculitis in a patient with Graves disease presenting as purpura fulminans

    Page :AB115

    
  • ·The emerging phenotype of ovarian driven autoimmunity: Annular, lateralizing, and microvesicular skin diseases in women

    Page :AB115

    
  • ·The value of trichoscopy in differential diagnosis of isolated scalp lesions in pemphigus

    Page :AB115

    
  • ·Treatment of coexisting pemphigus foliaceus and psoriasis with adalimumab

    Page :AB115

    

• Infection—Bacterial and Parasitic

  • ·Acute ulcerative lesions in HIV seropositive patient

    Page :AB116

    
  • ·Clinical exuberance of Hansen disease: Case report

    Page :AB116

    
  • ·Clinical management with endovenous corticotherapy in patients with leprosy reactions

    Page :AB116

    
  • ·Cutaneous larva migrans: An imported case

    Page :AB116

    
  • ·Demodicosis: Clinical, dermatoscopic, and microscopic correlation

    Page :AB117

    
  • ·Diagnosis of late multibacillary leprosy endemic country: Keeping still endemic?

    Page :AB117

    
  • ·Difficulty in diagnosing childhood leprosy

    Page :AB117

    
  • ·Disseminated Mycobacterium chelonae infection in a patient with relapsing polychondritis

    Page :AB117

    
  • ·Erysipelas-like cutaneous leishmaniasis in a white man

    Page :AB118

    
  • ·Erythema induratum of Bazin secondary to tuberculin skin test

    Page :AB118

    
  • ·Evaluation of 166 leprosy patients under 15 years of age in a public hospital, Rio de Janeiro/Brazil

    Page :AB118

    
  • ·Generalized granuloma annulare in patients with syphilis

    Page :AB118

    
  • ·Greater psychiatric morbidity in patients with bacterial infections of the skin versus cutaneous neoplasms: Analysis of an epidemiologic sample of 74,753 patient visits for dermatologic disorders

    Page :AB119

    
  • ·Hansen disease after etanercept treatment

    Page :AB119

    
  • ·How scabies crusts: Dermatoscopy aspects of Norwegian scabies

    Page :AB119

    
  • ·Late reversal reaction 6 months after completion of WHO standard treatment for multibacillary leprosy

    Page :AB119

    
  • ·Leprosy: Care for the prevention of plantar ulcer

    Page :AB120

    
  • ·Leprosy in children: A warning to endemic countries

    Page :AB120

    
  • ·Leprosy: Importance of differential diagnoses in an endemic area

    Page :AB120

    
  • ·Leprosy: The importance of investigating household contacts: A case report

    Page :AB120

    
  • ·Mites and burrows are frequently found in nodular scabies by dermatoscopy and histopathology

    Page :AB121

    
  • ·Mycetoma: A therapeutic challenge

    Page :AB121

    
  • ·Mycobacteria mucogenicum infection following a cosmetic procedure with poly-L-lactic acid

    Page :AB121

    
  • ·Mycobacterium abscessus infection occurring within lesions of gouty tophi

    Page :AB121

    
  • ·Necrobiontophage myiasis

    Page :AB122

    
  • ·Neuropathy in patients with leprosy and diabetes: The importance of clinical signs

    Page :AB122

    
  • ·Nodular leprosy in children

    Page :AB122

    
  • ·Oral lesions as the only manifestation of secondary syphilis

    Page :AB122

    
  • ·Outbreak of Panton–Valentine leukocidin–positive Staphylococcus aureus in dermatology inpatients in the UK: An escalating phenomenon?

    Page :AB123

    
  • ·Oxidative stress in type I lepra reaction and the effect of treatment

    Page :AB123

    
  • ·Papulonecrotic tuberculid revealing ganglionar tuberculosis

    Page :AB123

    
  • ·Scrofuloderma: A case report

    Page :AB123

    
  • ·Secondary syphilis with exuberant manifestations

    Page :AB124

    
  • ·Simultaneous primary and secondary syphilis in an HIV-positive patient

    Page :AB124

    
  • ·Tattoo inoculation leprosy in a patient treated for pulmonary tuberculosis

    Page :AB124

    
  • ·The Edinburgh experience of cutaneous Mycobacterium chelonae infection

    Page :AB124

    
  • ·The perils of breast plastic surgery

    Page :AB125

    
  • ·Therapeutic approach of leprosy in pregnancy

    Page :AB125

    
  • ·Unusual presentation of syphilis in HIV patients

    Page :AB125

    

• Infection—Fungal

  • ·An unusual epidemic of sporotrichosis in Rio de Janeiro

    Page :AB125

    
  • ·Analysis of diagnostic methods for onychomycosis

    Page :AB126

    
  • ·Atypical presentation of bilateral lynphatic cutaneous sporotrichosis

    Page :AB126

    
  • ·Criteria for onychomycosis mycologic cure: A second look

    Page :AB126

    
  • ·Cutaneous phaeohyphomycosis in an immunocompromised host

    Page :AB126

    
  • ·Delayed diagnosis of paracoccidioidomycosis: A typical case in a nonendemic area

    Page :AB127

    
  • ·Dermatoscopy findings in tinea capitis: A case report

    Page :AB127

    
  • ·Device-based therapies for onychomycosis

    Page :AB127

    
  • ·Disseminated cryptococcus with cutaneous involvement in the setting of sarcoidosis associated CD4⁺ lymphopenia

    Page :AB127

    
  • ·Disseminated mucormycosis

    Page :AB128

    
  • ·Drug susceptibility and resistance of fungal isolates in onychomycosis against efinaconazole

    Page :AB128

    
  • ·Feline sporotrichosis: Family case report

    Page :AB128

    
  • ·Juvenile form of paracoccidioidomycosis associated with exuberant hypoalbuminemia

    Page :AB128

    
  • ·Lobomycosis: A case with multiple lesions

    Page :AB129

    
  • ·Metastatic chromoblastomycosis

    Page :AB129

    
  • ·Naftifine hydrochloride gel 2% is effective as a topical therapy for moccasin-type tinea pedis

    Page :AB129

    
  • ·Naftifine hydrochloride gel 2% is efficacious and safe for the treatment of tinea pedis: Results from a randomized, multicenter, double-blind, vehicle-controlled study

    Page :AB129

    
  • ·Onychomycosis in children: Clinicomycologic study of 216 patients from Ibn-Sina University Hospital, Rabat

    Page :AB130

    
  • ·Atopic dermatitis and ichthyosis with generalized scaly erythematous skin lesions difficult to control: An unexpected diagnosis

    Page :AB130

    
  • ·Successful treatment of onychomycosis caused by Scytalidium dimidiatum by long-pulsed 1064 nm Nd:YAG laser and combination of laser treatment and 5% amorolfine nail lacquer: A case report

    Page :AB130

    
  • ·Tinea nigra palmaris: Case report and diagnostic options

    Page :AB130

    
  • ·Tinea pedis: A variant of eczema

    Page :AB131

    
  • ·Treatment of pityriasis versicolor with photodynamic therapy

    Page :AB131

    
  • ·Typical case of cutaneous-lymphatic sporotrichosis with good evolution after treatment

    Page :AB131

    

• Infection—Viral

  • ·Observation: A case of Merkel cell carcinoma infected by Merkel cell polyomavirus DNA

    Page :AB131

    
  • ·A case of vulvar eczema herpeticum

    Page :AB132

    
  • ·Adult-onset dermatomyositis complicated by chronic varicella zoster

    Page :AB132

    
  • ·An unusual case of orf on the face

    Page :AB132

    
  • ·Atypical lesions of human papillomavirus 16 in 1 year experience at specialized ambulatory: Are we aware?

    Page :AB132

    
  • ·Cutaneous parvovirus B19 infection associated with bowel disease

    Page :AB133

    
  • ·Difficulty in the treatment of patients with recurrent genital herpes and its clinical repercussion

    Page :AB133

    
  • ·Etiology of “recurrent herpes zoster”: A site-specific cohort

    Page :AB133

    
  • ·Gloves and socks syndrome caused by parvovirus B19 infection

    Page :AB133

    
  • ·Herpes folliculitis masquerading as cutaneous lymphoma

    Page :AB134

    
  • ·Herpes zoster: A review of cases seen at the National Skin Center, Singapore (2008-2010)

    Page :AB134

    
  • ·Herpes simplex virus–associated erythema multiforme as a potential paraneoplastic marker in cholangiocarinoma treated with yttrium-90 microsphere ablation

    Page :AB134

    
  • ·Kaposi sarcoma: No longer an AIDS-defining illness?

    Page :AB134

    
  • ·Patterns of disease and treatment of cold sores

    Page :AB135

    
  • ·The interferon-gamma release assay: Experience from a tertiary dermatology center in the tropics

    Page :AB135

    
  • ·Trichodysplasia spinulosa: Rare presentation of polyomavirus infection in immunocompromised patients

    Page :AB135

    
  • ·Varicella presenting with atypical skin lesions and fulminant hepatitis in an adolescent with leukemia: Disseminated vesicles with seborrheic distribution

    Page :AB135

    
  • ·Viral warts on tattooed skin: Koebner phenomenon

    Page :AB136

    

• Internal Medicine Dermatology

  • ·A case of scar sarcoidosis without systemic involvement

    Page :AB136

    
  • ·A rare cause of cutaneous metastasis

    Page :AB136

    
  • ·A survey of mortality in patients admitted to intensive care with skin disorders

    Page :AB136

    
  • ·Acanthosis nigricans as paraneoplastic of internal malignancy

    Page :AB137

    
  • ·An unusual case of metastatic well-differentiated endocrine carcinoma (carcinoid syndrome) presenting with a telangiectatic rash and flushing

    Page :AB137

    
  • ·Atypical presentation of sebaceous adenoma in a patient with familial colon cancer

    Page :AB137

    
  • ·Carboplatin-induced scleroderma in a patient with stage IV ovarian cancer

    Page :AB137

    
  • ·Cheilitis granulomatosa: Review of 3 new cases

    Page :AB138

    
  • ·Clinical factors associated with nephrogenic systemic fibrosis (NSF): A single site academic center, 2-cohort study

    Page :AB138

    
  • ·Demyelinating disease complicating adalimumab treatment of hidradenitis suppurativa

    Page :AB138

    
  • ·Eosinophilic vasculitis

    Page :AB138

    
  • ·Epidermal nevus syndrome with bilateral renal artery stenosis and midaortic syndrome

    Page :AB139

    
  • ·Histopathology and clinical features can predict the risk of renal and other systemic involvement in adult Henoch–Schönlein purpura

    Page :AB139

    
  • ·Intravenous immunoglobulin as a steroid-sparing agent in recalcitrant drug reaction with eosinophilia and systemic symptoms syndrome

    Page :AB139

    
  • ·Lichen planus pigmentosus in patients with endocrinopathies and hepatitis C

    Page :AB139

    
  • ·Methotrexate-induced pleurisy

    Page :AB140

    
  • ·Muckle–Wells syndrome: A case report

    Page :AB140

    
  • ·Paraneoplastic autoinmune multiorgan syndrome presenting with vitiligo and lung and liver involvement in the absence of detectable autoantibodies

    Page :AB140

    
  • ·Sarcoidal granulomatosis of the tongue: An isolated form of sarcoidosis?

    Page :AB140

    
  • ·Sarcoidosis presenting as subcutaneous finger and toe nodules

    Page :AB141

    
  • ·Schnitzler syndrome: A diagnostic and therapeutic challenge

    Page :AB141

    
  • ·Sebaceous hyperplasia in a renal transplant patient on sirolimus

    Page :AB141

    
  • ·The unexpected airway

    Page :AB141

    
  • ·Treatment of eczematoid and vitiliginous graft versus host disease with extracorporeal photopheresis and alemtuzumab

    Page :AB142

    
  • ·Treatment of vemurafenib-related cutaneous side effects with acitretin

    Page :AB142

    
  • ·Two cases of cutaneous involvement in chronic myelomonocytic leukemia: A rare type of leukemia cutis

    Page :AB142

    
  • ·Wegener granulomatosis of the penis

    Page :AB142

    

• Lymphoma, Cutaneous/Mycosis Fungoides

  • ·CD8-positive primary cutaneous T-cell lymphoma with peripheral and central nervous system involvement

    Page :AB143

    
  • ·A case of primary cutaneous anaplastic large cell lymphoma presenting with numerous patches, papules, and nodules in a child

    Page :AB143

    
  • ·A diagnostic challenge: Mycosis fungoides or psoriasis

    Page :AB143

    
  • ·Acute scleritis and nonerythrodermic skin rash: An unusual presentation of Sézary syndrome

    Page :AB143

    
  • ·Beware of the mottled red leg

    Page :AB144

    
  • ·Cutaneous NK/T-cell lymphoma presenting as targetoid lesions

    Page :AB144

    
  • ·Cutaneous T-cell lymphoma in patients with chronic lymphocytic leukemia

    Page :AB144

    
  • ·Diffuse large B-cell lymphoma leg type secondary to testicular diffuse large cell-B lymphoma

    Page :AB144

    
  • ·Does preemptive leucovorin use compromise the efficacy of pralatrexate in CTCL?

    Page :AB145

    
  • ·Elucidating the molecular pathogenesis of cutaneous T-cell lymphoma

    Page :AB145

    
  • ·Epidemiologic and clinical features of cutaneous T-cell lymphoma in a Mediterranean population

    Page :AB145

    
  • ·Epstein–Barr virus-associated hydroa vacciniforme–like cutaneous lymphoma and NK/T-cell lymphoma

    Page :AB145

    
  • ·Fluorescence diagnosis for follow-up of mycosis fungoides therapy

    Page :AB146

    
  • ·Granuloma annulare heralding relapse of angioimmunoblastic T cell non-Hodgkin lymphoma

    Page :AB146

    
  • ·Ichthyosiform mycosis fungoides: Clinicopathologic, immunophenotypic, and molecular features

    Page :AB146

    
  • ·Incidence of primary cutaneous T-cell lymphoma in Wales

    Page :AB146

    
  • ·Mycosis fungoides mimicking alopecia areata: A case report

    Page :AB147

    
  • ·Mycosis fungoides under anti–tumor necrosis factor-alfa therapy

    Page :AB147

    
  • ·Mycosis fungoides with large cell transformation masquerading as subacute cutaneous lupus erythematosus

    Page :AB147

    
  • ·Novel combination therapy for the treatment of cutaneous T-cell lymphoma

    Page :AB147

    
  • ·Plasmablastic lymphoma of the oral cavity: A case report

    Page :AB148

    
  • ·Primary cutaneous anaplastic large cell lymphoma: A diagnostic challenge

    Page :AB148

    
  • ·Primary cutaneous B-cell lymphoma: A case report

    Page :AB148

    
  • ·Primary cutaneous diffuse large B-cell lymphoma, leg type: Two Bcl-2 negative cases

    Page :AB148

    
  • ·Primary cutaneous T-cell lymphoma with epidermotrophic cytotoxic CD8⁺ phenotype: A case report

    Page :AB149

    

• Melanoma and Pigmented Lesions

  • ·Invasiveness of melanoma in patients exposed to artificial ultraviolet light in tanning beds

    Page :AB149

    
  • ·Accuracy of initial shave biopsy as a predictor of final stage upon definitive treatment in patients with thin melanomas

    Page :AB149

    
  • ·Amelanotic penile melanoma: A case report and review of the literature

    Page :AB149

    
  • ·Bilateral nevus of Ota and nevus of Ito

    Page :AB150

    
  • ·BRAF-positive folliculotropic metastatic melanoma

    Page :AB150

    
  • ·Clinical and dermatoscopic characteristics of desmoplastic melanomas

    Page :AB150

    
  • ·Clinical application of fluorescence in situ hybridization in the diagnosis and management of melanocytic lesions

    Page :AB150

    
  • ·Completely regressed primary cutaneous melanoma presenting with nodal metastasis: A case with sequential photographic evidence

    Page :AB151

    
  • ·Cutaneous recurrence in melanoma: A case series of 19 patients

    Page :AB151

    
  • ·Dermatoscopy of a second primary melanoma of the vulva

    Page :AB151

    
  • ·Diagnostic accuracy of smartphone application in evaluating pigmented skin lesions

    Page :AB151

    
  • ·Diffuse melanosis cutis: A systematic review of a rare presentation of metastatic melanoma

    Page :AB152

    
  • ·Eruptive dysplastic nevi after melanotan use

    Page :AB152

    
  • ·Horner syndrome secondary to metastatic malignant melanoma

    Page :AB152

    
  • ·Impact of guidance from a multispectral digital skin lesion analysis device on dermatology residents decisions to biopsy lesions clinically suggestive of melanoma

    Page :AB152

    
  • ·Influences on melanoma patients and their partners participation in skin self-examination educational research

    Page :AB153

    
  • ·Malignant melanoma, index and nonindex lesions

    Page :AB153

    
  • ·Melanomas with dark homogeneous streaks pattern may have specific KIT mutation

    Page :AB153

    
  • ·Multiple melanomas arising in a partial unilateral lentiginosis

    Page :AB153

    
  • ·Ocular melanoma metastatic to the skin: A case and review

    Page :AB154

    
  • ·Single-institution experience of high-dose interleukin-2 therapy for metastatic melanoma

    Page :AB154

    
  • ·Smartphone app for teledermatoscopy

    Page :AB154

    
  • ·Spitz nevi arising in speckled lentiginous nevus: Defining clinical, pathologic, and dermatoscopic features

    Page :AB154

    
  • ·The effect of full body skin examinations on the prognosis of melanoma

    Page :AB155

    
  • ·Tumor with 2 years’ development in the heel of a 71-year-old woman: A difficult diagnosis

    Page :AB155

    

• Nonmelanoma Skin Cancer

  • ·A case of dermatofibrosarcoma protuberans

    Page :AB155

    
  • ·A case of multiple actinic keratosis, Bowen disease, squamous cell carcinoma, basal cell carcinoma after PUVA therapy in a psoriasis patient

    Page :AB155

    
  • ·A pharmacokinetic study using a highly sensitive and specific method to determine systemic exposure of ingenol mebutate and its two main metabolites, PEP015 and PEP025 in human whole blood after topical administration

    Page :AB156

    
  • ·A phase II study of photodynamic therapy (PDT) with aminolevulinic acid HCl (ALA) 20% topical solution + blue light versus aminolevulinic acid HCl topical solution vehicle (VEH) + blue light for the treatment of actinic keratoses (AKs) on the upper extremi

    Page :AB156

    
  • ·A phase II study of photodynamic therapy (PDT) with aminolevulinic acid HCl (ALA) 20% topical solution + blue light vs ALA topical solution vehicle + blue light using spot and broad area application and incubation times of 1, 2 and 3 hours for the treatment

    Page :AB156

    
  • ·Abrikossoff tumor of the heel: A case report

    Page :AB156

    
  • ·Acute lymphoblastic leukemia mimicking leprosy

    Page :AB157

    
  • ·Adenosquamous carcinoma: A rare carcinoma treated with Mohs micrographic surgery and radiation

    Page :AB157

    
  • ·Angiosarcoma in a condensed sporotrichoid distribution arising at an ateriovenous fistula site: Case report

    Page :AB157

    
  • ·Assessing health-related quality of life (HRQoL) for advanced basal cell carcinoma (ABCC) and basal cell carcinoma nevus syndrome (BCCNS): Development of the first disease-specific patient-reported outcome (PRO) questionnaire

    Page :AB157

    
  • ·Betel nut and oral cancer

    Page :AB158

    
  • ·Classic Kaposi sarcoma in 2 HIV negative Hispanic women

    Page :AB158

    
  • ·Clinically inapparent basal cell carcinomas detect by stereoscopic high magnification dermatoscopy

    Page :AB158

    
  • ·Clinicopathologic correlation of MUC5AC expression in advanced extramammary Paget disease

    Page :AB158

    
  • ·Cost effectiveness analysis of Mohs micrographic surgery versus traditional surgical excision for head and neck basal cell carcinoma

    Page :AB159

    
  • ·Cutaneous Agent Orange syndrome

    Page :AB159

    
  • ·Cutaneous histiocytic sarcoma: A case report

    Page :AB159

    
  • ·Cutaneous metastasis of papillary thyroid carcinoma after total thyroidectomy

    Page :AB159

    
  • ·Cutaneous superficial leiomyosarcoma: A treatment conundrum

    Page :AB160

    
  • ·Cylindroma: Typical presentation of uncommon tumor

    Page :AB160

    
  • ·Dispelling the myth: Perceptions of skin cancer susceptibility in Fitzpatrick types IV to VI

    Page :AB160

    
  • ·Evaluating radiotherapy in basal cell carcinomas of the medial canthus

    Page :AB160

    
  • ·Evaluation of the definitions of “high-risk” cutaneous squamous cell carcinoma using the American Joint Committee on Cancer staging criteria and National Comprehensive Cancer Network guidelines

    Page :AB161

    
  • ·Free skin cancer screening provides access to care

    Page :AB161

    
  • ·Generalized trichilemmal cysts with an unfavorable outcome

    Page :AB161

    
  • ·Head and neck squamous cell cancer in parotid gland: Case report

    Page :AB161

    
  • ·Health communications encouraging sunscreen use in Hispanics

    Page :AB162

    
  • ·Intraoperative spectroscopic detection of protoporphyrin IX fluorescence by oral 5-aminolevulinic acid for margin control in nonmelanoma skin cancer

    Page :AB162

    
  • ·Keratoacanthoma centrifugum marginatum: Report of 3 patients

    Page :AB162

    
  • ·Mixed treatment comparisons metaanalysis of interventions for actinic keratosis

    Page :AB162

    
  • ·Mohs micrographic surgery is associated with a lower recurrence rate in patients with sebaceous carcinoma: An update of the Mayo Clinic experience over the past 2 decades

    Page :AB163

    
  • ·Not all basal cell carcinomas are created equal: A case of a fatal BCC

    Page :AB163

    
  • ·Phakomatosis pigmentokeratotica associated with multiple basal cell carcinomas

    Page :AB163

    
  • ·Pharmacodynamics of ingenol mebutate 0.05% gel for the treatment of actinic keratosis assessed by histology

    Page :AB163

    
  • ·Photodynamic therapy in the treatment of extensive Bowen disease

    Page :AB164

    
  • ·Plantar basal cell carcinoma: Case report

    Page :AB164

    
  • ·Postradiation sarcoma: Report of a case

    Page :AB164

    
  • ·Prognostic factors for the development of recurrence or metastases in patients with primary cutaneous mucinous carcinoma

    Page :AB165

    
  • ·Rare presentation of xanthelasma palpebrarum developed with Koebner phenomenon

    Page :AB165

    
  • ·Risk factors for nonmelanoma skin cancer in kidney transplant patients in a Spanish population

    Page :AB165

    
  • ·Risk of subsequent primary malignancies after dermatofibrosarcoma protuberans diagnosis: A national study

    Page :AB165

    
  • ·Spleen tyrosine kinase expression is a marker for ultraviolet light damage and nonmelanoma skin cancer

    Page :AB166

    
  • ·Stewart–Treves syndrome: A rare complication of lymphedema

    Page :AB166

    
  • ·Subcutaneous dermatofibrosarcoma protuberans of the head: An uncommon histologic subtype in an uncommon location

    Page :AB166

    
  • ·The use of 7 days of topical 5-fluorouracil to diagnose subclinical actinic keratosis that remain 3 months after 3 different actinic keratosis treatment protocols

    Page :AB166

    
  • ·Tolerability assessment of treatment areas up to 100 cm² with ingenol mebutate gel 0.05% in patients with actinic keratosis lesions

    Page :AB167

    
  • ·Topical treatment of murine squamous cell carcinoma with ingenol mebutate gel 0.25%

    Page :AB167

    
  • ·Treating squamous cell carcinomas with intralesional 5-fluorouracil: Case report of patient with multiple squamous cell carcinomas in the setting of vemurafenib treatment for melanoma

    Page :AB167

    
  • ·Umbilical basal cell carcinoma: An unusual location

    Page :AB167

    
  • ·Verrucous carcinoma: Beware of the wolf in sheep's clothing

    Page :AB168

    
  • ·Vulvar basal cell carcinoma: An unusual location

    Page :AB168

    

• Pediatric Dermatology

  • ·A papular granulomatous disorder with scarring in a child

    Page :AB168

    
  • ·A case of secondary anetoderma related to continuous insulin pump in a type 1 diabetic

    Page :AB168

    
  • ·A novel treatment for infantile hemangiomas: Topical timolol maleate gel

    Page :AB169

    
  • ·A pediatric case of Wells’ syndrome presenting as recurrent cellulitis from arthropod bites: Case report and review of the literature

    Page :AB169

    
  • ·A pilot quality of life instrument for older children with pruritus: Preliminary results

    Page :AB169

    
  • ·A rare case of severe chilblains in a young boy: Aicardi–Goutières syndrome or chilblain lupus?

    Page :AB169

    
  • ·A zosteriform variant of pigmented purpura secondary to the treatment of attention deficit hyperactivity disorder in a 6-year-old male

    Page :AB170

    
  • ·Acral erythrodysesthesia in a pediatric patient with acute lymphoblastic leukemia

    Page :AB170

    
  • ·Acral pseudolymphomatous angiokeratoma of childhood: A case report and review of the literature

    Page :AB170

    
  • ·Analysis of pediatric atopic dermatitis: The relationship between disease progression and total immunoglobulin E and percent positive immunocaps

    Page :AB170

    
  • ·Analyzing inpatient dermatology consultations for pediatric patients

    Page :AB171

    
  • ·Anetoderma of prematurity associated with continuous positive airway pressure

    Page :AB171

    
  • ·Apocrine hidrocystoma

    Page :AB171

    
  • ·Central sensitization: An underreported cause of chronic pain in vascular malformations

    Page :AB171

    
  • ·Chymotrypsin-like protease activity in the stratum corneum is increased in atopic dermatitis and upon washing with soap

    Page :AB172

    
  • ·Clinical familial capillary malformation: Arteriovenous malformation syndrome without RASA1 mutation

    Page :AB172

    
  • ·Congenital raised bands of infancy: Case report and review of literature

    Page :AB172

    
  • ·Cutaneous dermatophyte infections in a neonate and an infant

    Page :AB172

    
  • ·Diagnosis and treatment of congenital erythropoietic porphyria: A case study

    Page :AB173

    
  • ·Eccrine nevus: Case report in a child

    Page :AB173

    
  • ·Extensive milia in a neonate with congenital malformations: Oral-facial-digital syndrome type 1

    Page :AB173

    
  • ·Generalized vesicular skin lesions presented at birth in a newborn

    Page :AB173

    
  • ·Hemangioma family burden: Creation of a specific questionnaire

    Page :AB174

    
  • ·Idiopathic eruptive macular pigmentation

    Page :AB174

    
  • ·Infant formula as a trigger for urticaria multiforme

    Page :AB174

    
  • ·Infantile systemic hyalinosis: First Moroccan case

    Page :AB174

    
  • ·Kindler syndrome in India

    Page :AB175

    
  • ·Langerhans cell histiocytosis presenting as a “blueberry muffin baby”

    Page :AB175

    
  • ·Lessons for adapting quality of life instruments to children: A pilot pruritus pediatric QoL questionnaire

    Page :AB175

    
  • ·Macrocephaly–cutis marmorata telangiectatica congenita (M-CMTC) with cranial abnormalities and maternal factor V deficiency

    Page :AB175

    
  • ·Neurocutaneous melanosis: Prognosis and treatment options

    Page :AB176

    
  • ·Onychomadesis caused by a new Coxsackievirus subtype CV A6

    Page :AB176

    
  • ·Pediatric dermatologic diseases in ancient Greece

    Page :AB176

    
  • ·Primary cutaneous plasmacytosis

    Page :AB176

    
  • ·Propanolol for a pelvis syndrome-associated hemangioma

    Page :AB177

    
  • ·Recognizing and managing eczematous id reactions to molluscum contagiosum virus in children

    Page :AB177

    
  • ·Skin physiology and surface isotropy investigations in young children of different age groups compared to adults

    Page :AB177

    
  • ·Subcutaneous histiocytoid Sweet syndrome in an adolescent with Crohn's disease

    Page :AB177

    
  • ·Successful treatment of ulcerated infantile hemangioma associated with PELVIS syndrome using oral propanolol

    Page :AB178

    
  • ·Trends in the presence or absence of transaminitis and/or leukopenia in pediatric patients treated with methotrexate for inflammatory skin disease

    Page :AB178

    
  • ·Verrucous hemangioma leg: A challenging birthmark

    Page :AB178

    

• Pharmacology

  • ·Association of 5-⍺ reductase inhibitors and sexual dysfunction: A RADAR report

    Page :AB178

    
  • ·Conservative treatment of chondrodermatitis nodularis chronica helicis with topical nitroglycerin

    Page :AB179

    
  • ·Cost effectiveness analysis of botulinum toxin versus sympathectomy for palmar hyperhidrosis

    Page :AB179

    
  • ·Danazol-induced Stevens–Johnson syndrome in a patient with systemic lupus erythematosus

    Page :AB179

    
  • ·Dupuytren's contractures secondary to BRAF kinase inhibitor therapy

    Page :AB179

    
  • ·Eczema-like reactions induced by tumor necrosis factor–alfa antagonist agents

    Page :AB180

    
  • ·Efficacy and safety of ustekinumab in patients with psoriasis: Our clinical experience

    Page :AB180

    
  • ·Extramammary Paget disease nonconventional treatment

    Page :AB180

    
  • ·Mechanism of antifungal action of efinaconazole against causative onychomycosis fungi

    Page :AB180

    
  • ·Onychopharmacokinetics of terbinafine hydrochloride penetration from a novel topical formulation into the human nail in vitro

    Page :AB181

    
  • ·Patients adherence and biologic drug survival in dermatology: An Italian center experience

    Page :AB181

    
  • ·Ruxolitinib-associated exfoliative dermatitis

    Page :AB181

    
  • ·The effect of folate supplementation on methotrexate efficacy in psoriasis patients

    Page :AB181

    
  • ·Three separate clinical pharmacology studies evaluating the phototoxic, photosensitizing, and sensitizing/allergenic potential of ingenol mebutate gel

    Page :AB182

    
  • ·Topical rapamycin in facial angiofibromas: Assessment of clinical improvement and patient satisfaction in a series of 4 cases

    Page :AB182

    
  • ·Vemurafenib-associated endobronchial squamous cell carcinoma

    Page :AB182

    

• Photobiology, Phototherapy and Photosensitivity Diseases

  • ·Effects of light emitting diode in blood cells

    Page :AB182

    
  • ·A comprehensive clinical development approach to evaluate tolerance and acceptability of sunscreen products in consumers with sensitive skin

    Page :AB183

    
  • ·Achieving increased sun protection factor for a daily sunprotection product with no sensory negatives: A route to drive compliance

    Page :AB183

    
  • ·Acute photoinduced purpura

    Page :AB183

    
  • ·Annular elastolytic giant cell granuloma associated to late-onset erythtopoietic protoporphyria

    Page :AB183

    
  • ·Audit of phototherapy services in Wales, United Kingdom

    Page :AB184

    
  • ·Clinical improvement with 12-hydroxystearic acid: A cosmetic PPAR lipid for skin lightening benefits in photodamaged arms

    Page :AB184

    
  • ·Delayed, transient, sun-induced pruritus on the trunk: A report of 2 cases

    Page :AB184

    
  • ·Enhancing skin hydration with topical sunscreen formulations

    Page :AB184

    
  • ·Evaluation of sunscreens using the critical wavelength test

    Page :AB185

    
  • ·Exposure of pilots to ultraviolet radiation in the cockpit

    Page :AB185

    
  • ·Histologic and immunohistologic findings of multiple nonmelanoma skin cancer temoporfin treatment: Stimulation of antitumor immunity hyphothesis

    Page :AB185

    
  • ·Low-dose temoporfin and short drug-to-light interval is effective in the treatment of multiple nonmelanoma skin cancers

    Page :AB185

    
  • ·Oral versus bath psoralen plus ultraviolet A light phototherapy using 8-methoxypsoralen for chronic palmoplantar psoriasis

    Page :AB186

    
  • ·Photopatch testing: The 5-year experience in Singapore

    Page :AB186

    
  • ·Protective effects of a topical antioxidant complex containing vitamin C/E and ferulic acid on human skin induced by solar-simulated ultraviolet irradiation

    Page :AB186

    
  • ·Serious adverse events associated with UVA, psoralen-UVA and narrow-band UVB phototherapy in Spain

    Page :AB186

    
  • ·Successful treatment of scleredema diabeticorum by combining local psoralen plus ultraviolet A light phototherapy and colchicine

    Page :AB187

    
  • ·The effectiveness and tolerability of a combination of cosmetic foundations for photosensitivity in erythropoietic protoporphyria

    Page :AB187

    
  • ·Voriconazole-induced photosensitivity concerning for Stevens–Johnson syndrome

    Page :AB187

    

• Pigmentary Disorders and Vitiligo

  • ·A comparative study of safety and efficacy between 4% hydroquinone and 30% salicylic acid peel in treatment of periorbital hyperpigmentation in dark-skinned patients

    Page :AB187

    
  • ·Antioxidant activity and photoprotection of rutin succinate bioflavonoid

    Page :AB188

    
  • ·Clinical and instrumental assessment of a skin brightening cream containing vitamin C and licorice extract in patients with melasma

    Page :AB188

    
  • ·Clinical evaluation of the efficacy and tolerance of a product containing ellagic and salicylic acids in reducing hyperpigmentation and dark spots in comparison to 4% hydroquinone

    Page :AB188

    
  • ·Clinical predictors of comorbid autoimmune disease in vitiligo

    Page :AB188

    
  • ·Could idiopathic vitiligo possibly be contact vitiligo?

    Page :AB189

    
  • ·Cysteamine cream as a new skin depigmenting product

    Page :AB189

    
  • ·Double-blind, randomized, intraindividually controlled clinical trial to evaluate the efficacy of autologous melanocyte cell transplant using amniotic membrane as a scaffold in the treatment of stable vitiligo

    Page :AB189

    
  • ·Psychological stressors preceding vitiligo onset are associated with itch and intermittent abdominal cramping

    Page :AB189

    
  • ·The relationship between dermatologic diagnoses and consumer self-categorization of facial pigmentation

    Page :AB190

    
  • ·Time sequential changes of melanocytes and melanogenic factors in laser-induced postinflammatory hyperpigmentation

    Page :AB190

    
  • ·Trends in demographics and treatment for dyschromia

    Page :AB190

    
  • ·Vitiligo extent and distribution are associated with significant quality of life impairment

    Page :AB190

    

• Psoriasis and Other Papulosquamous Disorders

  • ·Work impairment and health care resource use in patients with psoriasis with or without psoriatic arthritis: Results from the PREPARE study

    Page :AB191

    
  • ·A 10-year postmarketing surveillance registry of adalimumab for moderate to severe psoriasis: Third-year interim results of ESPRIT

    Page :AB191

    
  • ·A case of recalcitrant psoriasis management with intensification therapy with golimumab

    Page :AB191

    
  • ·A pilot open-label clinical trial to test the efficacy and safety of the combination of 308 nm excimer laser with clobetasol spray followed by maintenance with topical calcitriol ointment in the treatment of moderate to severe psoriasis

    Page :AB191

    
  • ·Acitretin for the treatment of psoriasis: An assessment of national trends

    Page :AB192

    
  • ·Adalimumab for the treatment of psoriasis: A retrospective study of 51 patients

    Page :AB192

    
  • ·An approach to patient-centered care for patients with psoriatic arthritis

    Page :AB192

    
  • ·An evaluation of the effect of topical tofacitinib (CP-690, 550) on pruritus and patient satisfaction with study medication in a phase IIA trial for plaque psoriasis

    Page :AB192

    
  • ·Anti–tumor necrosis factor-alfa and psoriasis: New insights on keratinocyte differentiation markers

    Page :AB193

    
  • ·Anti–tumor necrosis factor-alfa–induced drug eruptions: One patient, more than a pattern

    Page :AB193

    
  • ·Apremilast improves pruritus in subjects with moderate to severe plaque psoriasis: Results from a phase IIB randomized, controlled study

    Page :AB193

    
  • ·Assessor-blinded study of the metabolic syndrome and surrogate markers of increased cardiovascular risk in children with moderate to severe psoriasis compared with an age- and sex-matched population of children with benign nevi, warts, or acne not treated with oral medications

    Page :AB193

    
  • ·Cardiovascular safety in the ustekinumab clinical development program: Final update with up to 5 years of follow-up

    Page :AB194

    
  • ·Foundation panel surveys

    Page :AB194

    
  • ·Characteristics of psoriasis patients with self-assessed limited disease control despite physician-assessed clear or minimal skin disease

    Page :AB194

    
  • ·Chronic psoriatic plaques contain newly identified CCL20-producing T_H1/T_H17/T_H22 subsets and clusters of CCR6⁺DC-LAMP⁺ mature myeloid dendritic cells: A possible pathogenic role of CCL20/CCR6 chemokine system in T cells/DCS interaction

    Page :AB194

    
  • ·Comfort level of dermatologists in prescribing systemic medications to elderly psoriasis patients

    Page :AB195

    
  • ·Comparative analysis of baseline characteristics of psoriatic arthritis trial patients treated with infliximab or golimumab

    Page :AB195

    
  • ·Comparison of patient reported outcomes by biologic treatment use in patients with moderate to severe plaque psoriasis: Results from a compiled dataset of National Psoriasis Foundation panel surveys

    Page :AB195

    
  • ·Comparison of the efficacy of biologics versus conventional systemic therapies in the treatment of psoriasis at a comprehensive psoriasis care center

    Page :AB195

    
  • ·Cost of etanercept and adalimumab in patients with psoriatic diseases with employer-provided health insurance

    Page :AB196

    
  • ·Costs of tumor necrosis factor blockers per treated patient with psoriatic disease using real-world drug usation data in a US managed care population

    Page :AB196

    
  • ·Crenotherapy and chronic inflammatory skin diseases: Impact on quality of life

    Page :AB196

    
  • ·Dermatitis herpetiformis Duhring as a rare comorbidity of psoriasis in a patient on biologic therapy

    Page :AB196

    
  • ·Desired improvement tool: A tool to assess desire for improvement in psoriasis patients

    Page :AB197

    
  • ·Detecting undiagnosed depression in patients with moderate to severe psoriasis: Development and validation of a risk score for use in dermatology

    Page :AB197

    
  • ·Differences in psoriasis severity and exposure to immunomodulatory therapies between cigarette smokers and nonsmokers: Observations from the PSOLAR registry in patients with moderate to severe psoriasis

    Page :AB197

    
  • ·Disseminated superficial porokeratosis in an immunocompetent patient

    Page :AB197

    
  • ·Double-dosing payment in psoriasis patients newly initiated on etanercept in US

    Page :AB198

    
  • ·Effect of adalimumab treatment on pruritus: A post-hoc analysis of the phase III, randomized REVEAL trial in patients with moderate to severe psoriasis

    Page :AB198

    
  • ·Effect of calcipotriene plus betamethasone dipropionate topical suspension/gel on the hypothalamic-pituitary-adrenal (HPA) axis and calcium homeostasis in patients with extensive psoriasis vulgaris: An open, noncontrolled, 8-week trial

    Page :AB198

    
  • ·Effect of secukinumab, a fully human anti–interleukin-17a monoclonal antibody on C-reactive protein levels in patients with moderate to severe plaque psoriasis: Result of a dose-ranging study

    Page :AB198

    
  • ·Effect of tumor necrosis factor–alfa inhibitor and methotrexate therapy on total cholesterol, high-density lipoprotein, and low-density lipoprotein in psoriasis/psoriatic arthritis and rheumatoid arthritis patients

    Page :AB199

    
  • ·Effects of golimumab on the dermatologic manifestations of psoriatic arthritis: 5-year results from the long-term extension of the randomized, placebo-controlled, GO-REVEAL study

    Page :AB199

    
  • ·Efficacy and safety of topical janus kinase inhibitor tofacitinib in the treatment of chronic plaque psoriasis: Results of a phase IIA randomized clinical trial

    Page :AB199

    
  • ·Erythema multiforme during treatment with interleukin-12 and interleukin-23 inhibitor

    Page :AB199

    
  • ·Erythrodermic psoriasis successfully treated with ustekinumab

    Page :AB200

    
  • ·Evaluation of cumulative life course impairment in psoriasis: A qualitative study

    Page :AB200

    
  • ·Evaluation of factors associated with cumulative life course impairment using a novel patient reported outcome for patients with psoriasis

    Page :AB200

    
  • ·Flare of preexisting psoriasis during rituximab therapy for Walderstrom macroglobulinemia

    Page :AB200

    
  • ·Genetic analysis of interleukins 12b, 23a, and 23r in Spanish population and psoriasis risk

    Page :AB201

    
  • ·Good response to moderate plaque psoriasis with ustekinumab in a patient with demyelinating disease and metabolic syndrome

    Page :AB201

    
  • ·Good syndrome and lichen planus

    Page :AB201

    
  • ·Interleukins -23 and -17 in patients with palmoplantar pustular psoriasis and palmoplantar pustulosis

    Page :AB201

    
  • ·Immunomodulatory effect of balneotherapy on imiquimod-induced psoriasis-like murine model

    Page :AB202

    
  • ·Impact of psoriatic arthritis on medical resource use, health status, and work productivity in the United States: 2011 National Health and Wellness Survey results

    Page :AB202

    
  • ·Improvement in patient reported symptoms and health related quality of life associated with achieving Psoriasis Area and Severity Index 100

    Page :AB202

    
  • ·Improvement in signs and symptoms of plaque psoriasis after 1 week of treatment with clobetasol propionate 0.05% spray

    Page :AB202

    
  • ·Improvement of psoriasis in subjects with and without previous brodalumab (AMG 827) treatment in an open-label extension study

    Page :AB203

    
  • ·Incremental medical service costs associated with escalating methotrexate dosage versus switching to adalimumab in patients with psoriasis

    Page :AB203

    
  • ·Infections in the ustekinumab psoriasis clinical trial program: Final report with up to 5 years of follow-up

    Page :AB203

    
  • ·Intra- and interrater reliability of the simplified psoriasis index

    Page :AB203

    
  • ·Inverse relationship between 25-hydroxyvitamin D and atherosclerosis in psoriatic patients

    Page :AB204

    
  • ·Inverse relationship between 25-hydroxyvitamin D and metabolic syndrome in patient with psoriasis

    Page :AB204

    
  • ·Investigation of the plasma homocysteine levels in patients with psoriasis

    Page :AB204

    
  • ·Koebnerized psoriasis is associated with early plasmacytoid dendritic cell infiltration

    Page :AB204

    
  • ·Lichen planus in a patient with chronic myeloid leukemia taking imatinib mesylate

    Page :AB205

    
  • ·Long-term costs of biologics in the treatment of moderate to severe psoriasis in the United States

    Page :AB205

    
  • ·Long-term safety of ustekinumab in patients with moderate to severe psoriasis through up to 5 years of continuous follow-up

    Page :AB205

    
  • ·Major adverse cardiovascular events in the psoriasis longitudinal assessment and registry (PSOLAR) study: Current status of observations

    Page :AB205

    
  • ·Malignancies in the ustekinumab psoriasis clinical development program: Final report with up to 5 years of follow-up

    Page :AB206

    
  • ·Malignancy events in the psoriasis longitudinal assessment and registry (PSOLAR) study: Current status of observations

    Page :AB206

    
  • ·Metabolic syndrome in psoriasis: Unusual findings from a South Indian cohort

    Page :AB206

    
  • ·Palmoplantar hyperkeratotic psoriasis with a combination of adalimumab and alitretinoin: Clinical and histologic finding

    Page :AB206

    
  • ·Phosphodiesterase 4 expression in psoriatic skin and apremilast modulation of inflammatory mediator production

    Page :AB207

    
  • ·Pityriasis rotunda

    Page :AB207

    
  • ·Plaque psoriasis and cutaneous mastocytosis: Report of a case

    Page :AB207

    
  • ·Porokeratosis ptychotropica responding to photodynamic therapy

    Page :AB207

    
  • ·Potential complications of psoriasis therapy: A case report and review of catastrophic antiphospholipid syndrome

    Page :AB208

    
  • ·Prevalence of psoriasis and rosacea comorbidities in the outpatient setting

    Page :AB208

    
  • ·PSOLAR: Global update of a multicenter, open registry of psoriasis patients

    Page :AB208

    
  • ·Psoriasiform and pustular eruption induced by tumor necrosis factor antagonists

    Page :AB208

    
  • ·Psoriasis and HIV/AIDS

    Page :AB209

    
  • ·Psoriasis rupioides, an uncommon form of a very common disease: A case report

    Page :AB209

    
  • ·Quality of life in patients with psoriasis treated with different modalities of phototherapy

    Page :AB209

    
  • ·Real-world treatment patterns for the first year of ustekinumab therapy in patients with moderate to severe psoriasis

    Page :AB209

    
  • ·Relationship between body regions and PASI clinical components for health-related quality of life: Subanalysis of REVEAL

    Page :AB210

    
  • ·Resolution of recalcitrant psoriatic plaques after treatment with gemcitabine and carboplatin

    Page :AB210

    
  • ·Risk of developing micro- and macrovascular complications in diabetes patients with psoriasis

    Page :AB210

    
  • ·Role of rheologic alterations on cardiovascular risk of psoriatic patients

    Page :AB210

    
  • ·Safe and effective approach of 4 immune-mediated inflammatory diseases with 1 biologic: Our results

    Page :AB211

    
  • ·Safety and efficacy of adding topical clobetasol propionate to etanercept in patients with moderate to severe plaque psoriasis

    Page :AB211

    
  • ·Screening for metabolic syndrome in psoriasis patients: Hurdles and solutions in a tertiary dermatologic hospital in Singapore

    Page :AB211

    
  • ·Secukinumab efficacy in moderate to severe psoriasis appears not to be affected by previous biologic use: Results of a phase II, dose-ranging trial

    Page :AB211

    
  • ·Secukinumab efficacy in moderate to severe psoriasis appears not to be affected by previous biologic use: Results of a phase II, regimen-finding trial

    Page :AB212

    
  • ·Secukinumab efficacy in patients with moderate to severe plaque psoriasis and psoriatic arthritis: A phase II, double-blind, randomized trial

    Page :AB212

    
  • ·Secukinumab reduces C-reactive protein levels in patients with moderate to severe plaque psoriasis: Result of a regimen-finding study

    Page :AB212

    
  • ·Secukinumab treatment shows a neutral effect on the lipid profile of patients with moderate to severe plaque psoriasis: Results from a randomized, double-blind, placebo-controlled, phase II study

    Page :AB212

    
  • ·Secukinumab treatment shows a neutral impact on the lipid profile of patients with moderate to severe plaque psoriasis in a dose-ranging study

    Page :AB213

    
  • ·Serious infection events in the psoriasis longitudinal assessment and registry (PSOLAR) study: Current status of observations

    Page :AB213

    
  • ·Serum chemokine profile in psoriasis

    Page :AB213

    
  • ·Study of enhanced ferritin/iron ratio in psoriasis

    Page :AB213

    
  • ·Subanalysis of the noninterventional study LOTOS: Correlation between measures of disease activity and identification of treatment response predictors in psoriasis patients treated with adalimumab during routine clinical care

    Page :AB214

    
  • ·Subanalysis of the noninterventional study LOTOS: Improved work ability status in psoriasis patients treated with adalimumab during routine clinical care

    Page :AB214

    
  • ·Subanalysis of the noninterventional study LOTOS: Patient-oriented outcomes in psoriasis patients treated with adalimumab during routine clinical care

    Page :AB214

    
  • ·Systemic sarcoidosis induced by adalimumab

    Page :AB214

    
  • ·The effects of adalimumab on C-reactive protein and sleep in moderate to severe psoriasis patients with suboptimal response to etanercept, methotrexate, or phototherapy: Subanalysis of the PROGRESS study

    Page :AB215

    
  • ·The psoriasis patient narrative study: An update on an ongoing patient-centered outcomes research study exploring the experience of living with moderate to severe plaque psoriasis

    Page :AB215

    
  • ·The role of the adiponectin levels and insulin resistance in psoriasis: Effects of cardiovascular disease risk factors

    Page :AB215

    
  • ·Tumor necrosis factor–alfa antagonist-induced lupus-like syndrome

    Page :AB215

    
  • ·Tolerability of ustekinumab in psoriasis of moderate to high degree associated to Berger disease

    Page :AB216

    
  • ·Treatment of pityriasis rubra pilaris with ustekinumab

    Page :AB216

    
  • ·Treatment of refractory pityriasis rubra pilaris with etanercept

    Page :AB216

    
  • ·Treatment patterns in the first year for biologic-naive psoriasis patients starting on etanercept and adalimumab in a pharmacy benefit management setting

    Page :AB216

    
  • ·Undiagnosed psoriatic arthritis in some patients under ustekinumb treatment for psoriasis: Radiologic evolutions of joints involved in the subsequent diagnosis of psoriatic arthritis

    Page :AB217

    
  • ·US treatment patterns in psoriasis pts newly initiated on etanercept or adalimumab

    Page :AB217

    
  • ·Ustekinumab in active psoriatic arthritis including patients previously treated with anti–tumor necrosis factor agents: Week 24 results from PSUMMIT 2, a phase III, multicenter, double-blind, placebo-controlled study

    Page :AB217

    
  • ·Ustekinumab in clinical practice: Experience from a single center in Spain

    Page :AB217

    
  • ·Ustekinumab in patients with active psoriatic arthritis: Results of the phase III, multicenter, double-blind, placebo-controlled PSUMMIT I study

    Page :AB218

    
  • ·Validation of the physician's global assessment of psoriasis of the hands and/or feet as a clinical endpoint

    Page :AB218

    
  • ·Verrucous psoriasis: A clinical and histopathologic mimicker of verruca vulgaris

    Page :AB218

    
  • ·Vitamin D: Serum level and its correlation with psoriasis severity

    Page :AB218

    

• Surgery—Cosmetic

  • ·John H. Woodbury and his 19th century cosmetic surgery empire

    Page :AB219

    
  • ·Postreconstruction dermatitis of the breast

    Page :AB219

    
  • ·Severe systemic reaction associated with skin microneedling therapy in 2 sisters: A previously unrecognized potential for complications?

    Page :AB219

    

• Surgery—Dermatologic

  • ·Comparative effectiveness of suction-curettage and onabotulinumtoxin-A injection for the treatment of primary focal axillary hyperhidrosis

    Page :AB219

    
  • ·Direct brow lift following Mohs-induced temporal nerve transection

    Page :AB220

    
  • ·Does Mohs micrographic surgery preserve tissue and key structures in the periocular area?

    Page :AB220

    
  • ·Hypnotically induced relaxation and self-guided imagery effectively reduces anxiety during dermatologic procedures

    Page :AB220

    
  • ·Keloid core excision with a suction-assisted cartilage shaver: 4 cases

    Page :AB220

    
  • ·Management of lentigo maligna: A surgical conundrum

    Page :AB221

    
  • ·Medial eyebrow defects: Reconstruction with whole eyebrow subcutaneous island pedicle

    Page :AB221

    
  • ·Multiple piloleiomyoma treated with suction-assisted cartilage shaver

    Page :AB221

    
  • ·Prolonged dorsal nasal flap with superiorly based nasolabial flap for large nasal tip defects: One-stage reconstruction

    Page :AB221

    
  • ·Rationale for antibiotic prophylaxis in patients with ventriculo-peritoneal shunts undergoing dermatologic surgery

    Page :AB222

    
  • ·Retrospective evaluation of the safety of large skin flap and graft surgery in the outpatient setting

    Page :AB222

    
  • ·Role of surgery in treatment of keloid: Preliminary results of an online survey

    Page :AB222

    
  • ·The Munich method: A variation of micrographic surgery hidden for decades

    Page :AB222

    
  • ·The use of fibrin glue in osmidrosis surgery with a cartilage shaver: 18 patients

    Page :AB223

    
  • ·When a cyst is not a cyst

    Page :AB223

    

• Surgery—Laser

  • ·A severe case of Favré–Racouchot syndrome: An absolute indication for the full ablative superpulsed CO₂ laser

    Page :AB223

    
  • ·A single-center, prospective study on the efficacy and safety of microfocused ultrasound for the noninvasive treatment of skin wrinkles above the knee

    Page :AB223

    
  • ·Adverse events of nonablative fractional laser photothermolysis: A retrospective study of 856 treatments in 362 patients

    Page :AB224

    
  • ·Intense focused skin tightening ultrasound in face and neck

    Page :AB224

    
  • ·Keloid scars in type VI skin treated with a combination of surgery and pulsed dye laser therapy

    Page :AB224

    
  • ·Long-pulsed alexandrite laser for treatment of hidradenitis suppurativa

    Page :AB224

    
  • ·Management of mild to moderate rhinophyma with ablative fractional photothermolysis

    Page :AB225

    
  • ·Multiphoton microscopy for monitoring CO₂ laser–skin interaction in vivo

    Page :AB225

    
  • ·Plexiform neurofibroma responding to Q-switched 532-nm Nd:YAG laser

    Page :AB225

    
  • ·Report of experience on 1927-nm fractional thulium fiber laser for the treatment of nonfacial areas

    Page :AB225

    
  • ·The efficacy of combination therapy with a novel continuous dermal heating monopolar radiofrequency device and botulinum toxin type A for facial contouring: A split-face study

    Page :AB226

    
  • ·Treatment of melasma in Asian skin enhanced penetration tranexamic acid using a ultrasound after plasma fractional radiofrequency

    Page :AB226

    
  • ·Treatment of primary axillary hyperidrosis with subdermal Nd:YAG laser

    Page :AB226

    
  • ·Treatment of the skin lesions of mastocytosis with different types of laser

    Page :AB226

    

• Wound Healing and Ulcers

  • ·Chronic ulcers in levamisole-adulterated cocaine abusers: Clinicopathologic variants from the same exposure

    Page :AB227

    
  • ·Efficacy of a topical gel containing extractum cepae, allantoin, and heparin in the treatment of abdominal caesarean section scars

    Page :AB227

    
  • ·Fidgetin-like 2 siRNA-loaded nanoparticles enhance and accelerate wound healing in a murine wound model

    Page :AB227

    
  • ·Impact of 5% dapsone gel on the healing time of an ankle ulcer formed after Achilles tendon rupture

    Page :AB227

    
  • ·Multiple skin lesions identical in size and morphology on the forearm of a 45-year-old woman: What is your diagnosis?

    Page :AB228

    
  • ·The impact of extracorporeal shock wave therapy at chronic wound healing

    Page :AB228

    
  • ·The use of a metalloproteinases diagnostic tool in pyoderma gangrenosum

    Page :AB228

    
  • ·The use of topical emollients in postoperative wound care among Mohs surgeons

    Page :AB228

    
  • ·Topical cyclosporin as a novel treatment for pyoderma gangrenosa

    Page :AB229

    
  • ·Two cases of nicorandil-induced ulceration mimicking skin malignancy

    Page :AB229

    
  • ·Ulcer dermatosis

    Page :AB229

    
  • ·Disclosure of relevant financial relationships

    Page :AB230

    Plan Plan
  • ·Alphabetic index to abstract authors : Abstract numbers in bold type indicate first author.

    Page :AB277

    Plan Plan
  • ·Subject index

    Page :AB292

    Plan Plan